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iAbstract
Helicobacter pylori is a human pathogen and the causative agent of chronic gastritis, 
peptic ulcer and gastric malignancies. A number of H. pylori virulence factors have 
been described including, CagA, VacA, neutrophil activating protein, and expression 
of receptors for binding to extracellular matrix proteins (adhesins). H. pylori interacts 
with extracellular matrix (ECM) proteins such as collagen IV, laminin, vitronectin 
and fibronectin, that can be exposed due to loss of integrity of the gastric epithelial 
cell layer. These interactions may be important in the pathogenesis of the organism.
This study examines the interaction of H. pylori with collagen IV in an attempt to 
identify a H. pylori collagen IV adhesin. Collagen IV makes up a large proportion of 
the basement membranes, and has been implicated in microbial adherence. FITC 
labelling of bacteria and a bacteria overlay method showed binding of H. pylori to 
ECM proteins collagen IV, laminin and fibronectin. Binding was observed under a 
variety of culture conditions. Receptor activity-directed tagging known as 
“Retagging” was employed in an attempt to purify the collagen IV adhesin. H. pylori
catalase was identified as a possible collagen adhesin, This enzyme was isolated and 
its interaction with collagen IV in vitro was studied. However, in vitro binding of 
collagen IV to catalase could not be demonstrated despite repeated attempts.
Immunoblot and receptor overlay techniques were investigated in further attempts to 
identify the H. pylori collagen IV binding protein. The role of collagen IV in H. pylori
ECM binding is discussed.
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1Chapter 1
Introduction
2(1.0) Introduction
(1.1) Helicobacter pylori
Helicobacter pylori (Figure 1.1) is a gram negative, flagellated, spiral shaped bacterium
found in the gastric mucosa of humans. Marshall and Warren first discovered the 
bacterium when they cultured it from a gastric biopsy (Marshall and Warren, 1984). It is 
a causative agent in gastritis, both peptic and duodenal ulcer disease (Morris & 
Nicholson 1987, and Blaser 1992), and is a risk factor for gastric carcinoma and 
mucosal-associated-lymphoid-tissue (MALT) lymphoma (Parsonnet et al., 1991).
Figure.1.1 Helicobacter pylori
H. pylori colonises a hostile gastric environment where few other organisms can 
survive, with a tissue tropism for the gastric mucosa of humans. Tissue tropism is the 
bacterial preference for certain tissues for growth. The bacteria survives the low pH of 
the stomach by producing urease. Urease hydrolyzes urea into ammonia and carbon 
dioxide, thus buffering the pH of the microenvironment surrounding the bacteria. H. 
pylori is sensitive to oxygen and therefore requires a microaerophillic atmosphere of 5% 
3O2 and 5-10% CO2 for growth. Another important colonisation factor for the bacterium 
is the possession of two to six polar sheathed flagellae, with two types of filaments 
encoded by the flaA and flab genes. These flagellae are essential for H. pylori motility,
allowing the bacterium to propel itself through the mucus layer of the stomach 
(Suerbaum et al., 1993, and Josenhans et al., 1995).
The proposal that this bacterium could cause gastric disorders was initially greeted with
scepticism. In order to convince colleagues, and the public, that this bacterium could 
cause disease such as gastritis and peptic ulcers, Barry Marshall drank a cultured
suspension of H. pylori, and showed it caused stomach inflammation, a potential 
precursor of an ulcer (Marshall et al., 1985). Once established in the gastric mucosa, the 
bacterium usually persists for life unless treated with antibiotics.
(1.2) Epidemiology of H. pylori Infection
Helicobacter pylori is thought to infect about 50% of the worlds population, and is one 
of the most common bacterial pathogens in humans. Although infection occurs 
worldwide, the overall prevalence of H. pylori infection in developed countries is lower 
than that in developing countries. In developing countries, 70 – 90% of the population 
carries H. pylori, whereas 25 – 50% of the population in developed countries carry the 
pathogen. The majority of all H. pylori infections are initiated in early childhood. In 
most developed countries the prevalence of infection is substantially lower at all ages 
(Karaca et al., 2004). Primary acquisition in adults, or reinfection after eradication does 
occur, but is less common. Prevalence can vary by ethnicity, place of birth, and socio-
economic groupings among people living in the same country. However, infection is 
decreasing in many areas due to improvements in sanitation and living standards. Many 
of those carrying H. pylori are asymptomatic, but all, without exception, have 
4inflammation of the stomach lining, a condition termed gastritis. Gastritis is an 
underlying condition, which eventually gives rise to ulcers and other digestive 
disorders.
The mode of transmission of H. pylori is unclear, but it is thought that the most likely
route of transmission is person to person contact, including oral to oral and fecal to oral 
transmission. Gastroenterologists or endoscopists may acquire infection through 
patients, and patients may acquire infection when an endoscope used on one patient is 
used on another. As a result of the association of H. pylori with peptic ulcer disease
(Figure 1.2), gastric cancer and malt lymphoma, intervention strategies to prevent the 
spread of this bacterium are urgently needed.
(1.3) Clinical Manifestation of Helicobacter pylori Infection
Once infected the typical course of infection begins with superficial gastritis. If left 
untreated infection can lead to gastric adenocarcinoma. Hardin & Wright (2002), report 
that H. pylori infection is associated with an increased rate of development of gastric 
carcinoma by a factor of up to 90-fold. A selection of host factors may also contribute to 
carcinoma development. The pro-inflammatory cyclooxygenase (COX)2 has been 
associated with this increased risk of developing gastric cancer. This enzyme catalyses 
reactions which promote the formation of inflammatory prostaglandins, and 
overexpression of (COX)-2 has been shown in patients with both Helicobacter pylori
CagA+ (Cag positive strain) infection and gastric cancer (Menaker et al., 2004).
Host genetics also play an important role in determining the outcome of a H. pylori
infection. For example polymorphisms of the IL-1 cytokine are known to be associated 
with a greater risk of cancer (Crowe, 2005).
5Potentially, the combination of host and bacterial genotyping may yield clues to the 
identification of patients with a high risk of developing H. pylori associated gastric
cancer.
Figure 1.2. Schematic of Helicobacter pylori induced peptic ulcer disease.
Taken from http://nobelprize.org/nobel_prizes/medicine/laureates/2005/press.html
Infection
Helicobacter pylori
infects the lower part of 
the stomach antrum
Inflammation
Helicobacter pylori
causes inflammation of 
the gastric mucosa 
(gastritis). This is often 
asymptomatic.
Ulcer
Gastric inflammation may lead to 
duodenal or gastric ulcer. Severe 
complications include bleeding 
ulcer and perforated ulcer.
Helicobacter pylori
Increased acid secretion
Inflammation Inflammation
6(1.4) Virulence Factors
The human stomach is a harsh environment, bathed in gastric juices composed of 
digestive enzymes and HCl, where food, bacteria, and viruses are all consumed. 
Helicobacter pylori has developed the ability to survive in the ecological niche of the 
human stomach with the aid of several virulence factors. These are described below and 
summarised in Table 1.1
(1.4.1) Urease
The gastric mucus protects the stomach from its own gastric juice. H. pylori colonises 
the mucus where it may come into contact with stomach acid. To protect itself against 
acid damage, H. pylori possesses an enzyme called urease. This enzyme hydrolyses urea 
into carbon dioxide and ammonia, thus neutralizing an area surrounding the bacterium.
The reaction is catalysed by urease is:
(NH2)C0 + H20 → C02 + 2NH3
Urease may contribute to mucosal damage in addition to conferring acid resistance on 
H. pylori, since it can stimulate upregulation of the inducible NO synthase (iNOS) 
(Gobert et al., 2002). However, urease may not be the only component involved in acid 
resistance. It has been reported that urease-negative H. pylori were capable of both 
colonization and inducing gastric ulcer formation in Mongolian gerbils (Mine et al.,
2005). H. pylori urease can also act as an adhesion factor (Beswick et al., 2006).
Although urease is a cytoplasmic protein in log phase bacteria, urease has been found 
on the cell surface of H. pylori, thought to be a result of bacterial lysis or release. Urease 
present on the bacterial surface binds to class II MHC molecules and CD74.
7(1.4.2) VacA
Approximately 50% of H. pylori strains produce a vacuolating toxin (VacA), which 
induces large cytoplasmic vacuoles in cultured eukaryotic cells (Leunk et al., 1988).
Studies have shown that it is a major virulence factor that is involved in the 
pathogenesis of inflammation in H. pylori (Papine et al., 2001, Prinz et al., 2003 and 
Peek 2003). Mature, soluble, 88kDa VacA proteins are secreted into extracellular space 
(Cover and Blaser, 1992), but have also been found to localise on the surface of H. 
pylori (Ilver et al., 2004). The 88kDa VacA protein can be subdivided into two domains 
p37 (amino terminal) and p 53(carboxyl terminal). The p37 domain is thought to have 
vacuolating activity, while the p58 domain is believed to be involved in VacA binding 
to the cell. Native VacA in H. pylori culture medium exists as a large oligomer with a 
mass of approximately 1000 kDa. The oligomer is composed of two rings consisting of 
6-7 VacA monomers, in a flower like shape. Under acidic or alkaline conditions the 
oligomer dissociates into monomers, increasing the vacoulating activity (Cover et al., 
2007, and Yahiro et al., 1999). 
VacA has been shown to play a role in colonization of the stomach. Although studies 
have shown that VacA negative mutants are capable of colonisation of mice and gerbils, 
Salama et al., (2001), has shown that a VacA producing H. pylori strain had a selective 
advantage over a VacA mutant strain, in colonisation of a mouse stomach.
(1.4.3) Cytotoxin associated geneA – CagA
CagA is an 128kDa immunogenic protein. Antibodies for CagA are detected in up to 
80% of H. pylori infected persons. It is used as a marker for a large pathogenicity island
- a genomic island which is acquired by horizontal gene transfer.
8They are incorporated in the genome of pathogenic microorganisms and encode many 
proteins implicated in pathogenesis. This CagA pathogenicity island is a means of 
making a distinction among H. pylori stains, as the 40kb region is present or absent 
among strains. CagA was the first gene discovered on the island. CagA positive strainss 
have been shown to be much more interactive with the host than CagA negative strains. 
CagA is also associated with VacA (Censini et al., 1996), and strains with both proteins 
have been implicated in disease at higher frequencies than those without. The CagA
Pathogenicity Island (PAI) has a type IV secretion system which allows CagA to be 
delivered into epithelial cells. CagA is also tyrosine phosphorylated, which allows it to 
interact with many host signalling molecules. It has recently been shown that CagA 
injection into host gastric epithelial cells, can induce NF-kB activation and IL-8 
production.
(1.4.4) Helicobacter pylori Adhesins
Specific adhesion to host tissue and cells is an essential virulence factor for most 
bacterial pathogens. The initial step of H. pylori colonisation involves the adhesion of 
the bacterium to human gastric epithelial cells, mediated through interactions between 
H. pylori adhesins and host cell receptors. Adhesion is directly linked to pathogenicity 
of the organism, and H. pylori that does not adhere to gastric mucosa tends to be 
removed by shedding of surface epithelial cells and the mucous layer.
Adhesins are present on the outer membrane of H. pylori, and two of the best known 
adhesins are BabA and SabA, which bind to fucosylated and sialylated blood group 
antigens respectively. Bacterial adhesion can result in multiple outcomes depending on 
the host cell receptor engaged (Testerman et al., 2001). For example, adherence of 
bacteria to host cell receptors may trigger cellular changes such as signal transduction 
9cascades, which in turn can lead to inflammation and eventually to persistence of the 
microorganism (Kronvall & Jonsson, 1999). Adhesins can be surface exposed or 
released by the bacterium. H. pylori also expresses adhesins with affinity for the 
Extracellular Matrix, which allows the bacterium to gain access to the subepithelial 
layer through intercellular tight junctions. Identifying adhesins may prove important in 
the development of strategies against H. pylori infection. It is of considerable current 
interest to analyze the mechanism of adhesion, and the interactions between the 
adhesins and the receptors. It may be possible to inhibit the adhesin as a mechanism for 
the prevention of H. pylori colonisation.
Table 1.1 Virulence factors in Helicobacter pylori
Virulence Factor Function and size Reference
CagA 128 kDa Immunogenic 
protein
Censini et al 1996
VacA Vacuolating toxin Telford et al 1994
Urease Enzyme - hydrolyses urea 
into carbon dioxide and 
ammonia
Mobley et al 1997
Catalase Enzyme – protects 
bacterium from oxygen 
toxicity
Hazell et al1991
BabA Lewis B binding adhesin Ilver et al 1998
Flagellar proteins Motility Lingwood et al 1993
Suerbaum et al 1993
O’Toole et al 1994
HP-NAP Neutrophil activating 
protein
Evans et al 1995
Table adapted from Pantzar 1999.
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Patient
Smoking
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treatment
H. pylori
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Treatment
Side effects
(1.5) Treatment of H. pylori Infection
Many factors have to be taken into consideration when designing treatments for the 
successful eradication of H. pylori (Figure 1.3). For example, the harsh environment of 
the human stomach can be a difficult environment for medicines. Development of
antibiotic resistance is also proving to be a problem. Many current treatments involve 
taking a large number of pills per day, thereby causing difficulties for the patient, as 
well as side effects. 
Figure 1.3. Factors to consider in the treatment of Helicobacter pylori infection.
Current treatment uses a triple therapy, a combination of two antibiotic agents 
administered with an adjunctive agent, such as a proton pump inhibitor. Omeprazole is a 
widely studied proton pump inhibitor, which reduces acid production and raises the pH 
11
in the stomach. A proton pump inhibitor may be used along with a combination of 
meatronidazole, clarithromycin, amoxicillin, and tetracycline antibiotics. Antimicrobial 
resistance and incomplete treatment are the major reasons underlying treatment failure.
This has made it necessary in some cases to use a quadruple therapy using four 
antibiotics and a proton pump inhibitor (Malfertheiner et al, 2002). Some current 
treatment regimens for Helicobacter pylori infection are outlined in Table 1.2.
Table 1.2. Treatment Regimens for Helicobacter pylori Infection
Triple Therapy 1 Triple Therapy 2 Quadruple 
Therapy 1
Quadruple 
Therapy 2
Omerprazole (PPI)
      
         or
Ranitidine bismuth 
citrate 
       and
Bismuth 
subsalicylate
       and
Bismuth 
subsalicylate
        and
Lansoprazole  (PPI)
        and
Clarithromycin
      or
Metronidazole
        
       and
Metronidazole
        
         and
Metronidazole 
         or
Metronidazole
      and
Tetracycline
        and
Tetracycline
         and
Amoxicillin 
        and
Amoxicillin
       or
H2RA PPI
Clarithromycin Tetracycline
Adapted from Malfertheiner et al, 2002.
In addition to antibiotic resistance, prohibitive costs of treatment, especially in 
developing nations where H. pylori infection is endemic, may add to the problems 
surrounding successful treatment and eradication (Ruggiero et al, 2003).
Some workers have suggested that immunisation may be a more appropriate treatment 
of H. pylori infection (Hardin & Wright, 2002). The availability of a safe, effective, and 
cost effective vaccine would be a potential benefit to society.
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(1.6) Collagen IV
Collagens are a large family of proteins that are found in all multicellular animals, and are 
responsible for a wide variety of functions, such as cell migration, cell adhesion, as well as
playing a structural role in tissue integrity. At least 28 different collagens occur in 
vertebrates. Although there is no agreed definition for a collagen, they are regarded in 
general as triple helicle proteins that function in tissue assembly and maintenance (Kadler 
et al, 2007). Table 1.3 shows a list of some of the known collagens and their properties.
Collagen IV is a large structural protein, found exclusively in basement membranes, and 
makes up a large component of the mammalian extracellular matrix (ECM) (Kefalides 
1973). This collagen is also termed network forming due to its ability to self assemble into 
organized networks. This property makes type IV collagen different to the fibrillar forming 
collagens (types I, II, & III). Collagen IV is composed of three domains (Figure.1.4.A). The 
first is a central triple helical structure, where 3 polypeptide chains called α chains are 
wound around one another in a rope-like superhelix (Figure.1.4.B). This structure is rich in 
glycine, and is composed of a series of Gly-X-Y sequences, where X and Y are frequently 
occupied by proline and hydroxyproline residues. The other two domains are the N terminal 
(7S) domain and the C terminal Globular (NC1) domain. Disulfide bonds link the NC1 
domain of one molecule to the same domain of another, while 7S domains associate to form 
cross links (Furthmayr, 1993). There are 6 distinct α chain polypeptides in mammalian 
collagen IV, which have 
13
Table 1.3: Collagens and their Polymerised Form and Tissue Distribution
Type Polymerised Form Tissue Distribution
Fibril Forming I fibril Bone, skin, tendons
Ligaments, cornea, 
internal organs
II fibril Cartilage, 
invertebral disc, 
notochord
III fibril Skin, blood vessels 
internal organs
V fibril As with type I
XI fibril As for type II
Fibril Associated IX Lateral association 
with type II fibrils
Cartilage
XII Lateral association 
with some type I 
fibrils 
Tendons, ligaments, 
some other tissues
Network Forming IV Sheetlike Network Basal Lamina
VII Anchoring fibrils Beneath stratified 
squamous epithelia
Transmembrane XVII Not known hemidesmosomes
Other XVIII Not known Basal lamina around 
blood vessels
Adapted from Kadler et al., 2007.
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similar domain structures and have between 50-70% homology at the amino acid level 
(Hudson et al, 1993 and Kalluri, 2003).
(A)
(B)
Figure 1.4: Schematic showing (A) the three domains of the Collagen IV α chain, and (B), the 
triple helical structure composed of three α chains (Kalluri 2003).
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Although collagen IV plays a key role in scaffolding of the ECM, other biological roles, 
such as binding of collagen IV to cells, proteins or bacterial adhesins, may be just as 
important to explore. Collagen IV is found exclusively in basement membranes; the 
extracellular structures which under-lays most epithelial cells and surrounds muscle, 
smooth muscle cells nerves and fat. The ability of a microorganism to adhere to such an
ubiquitous protein would be an obvious advantage for pathogenesis. Several bacterial
species have shown binding to collagen IV including Enterococcus faecalis (Xiao et al.,
1998), Psuedomonas aeruginosa (de Bentzmann et al., 1996) and Staphylococcus aureus
(Switalski et al., 1989).
Trust et al (1991) first reported binding of Heliocbacter pylori to collagen IV. Testing 
various H. pylori isolates, it was found that binding occurred at high levels (average 
binding 27%, highest binding 60%) and was of high affinity (Kd = 16nM). Binding was also 
found to be rapid, insensitive to pH and saturable. Boiling the cells and treating with either 
trypsin or protein kinase K, significantly reduced binding indicating that binding is most 
likely mediated by surface proteins present on the bacterial surface. Reduced binding also 
occurred for bacteria that were treated for 20 minutes at 80ºC. This temperature does not
denature the proteins but causes a perturbation of macromolecular assembled proteins. 
From this data Trust et al, suggest that a supermolecular protein structure such as a fimbria
(a proteinaceous appendage in many Gram-negative bacteria) might be involved in binding.
H. pylori binding to collagen IV could be important for colonization and invasion of the 
basement membranes and the lamina propria in the process of eliciting ulcerative lesions.
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(1.7) Laminin
Laminin is a large non collagenous protein which makes up a significant part of basement 
membranes. The first laminin trimer was isolated from a Engelbreth-Holm-Swarm tumour 
(Chung et al, 1979, and Timpl et al, 1979). The structure of a typical laminin molecule
(Figure 1.5) is made up of 3 chains held together by disulfide and non-covalent bonds in a 
cross shaped structure. The first chain is an A chain ~ 400kDa. The remaining two chains 
are made up of a B1 chain, and a B2 chain each approximately 220kDa, which associate 
forming a cross linked structure (Chung, 1995). Laminin has a large globular domain at its 
base as well as smaller globular domains on each arm (Chung, 1993).
Figure 1.5: Structure of Laminin. Laminin consists of three polypeptide chains designated A, B1 
and B2. Binding sites for entactin, collagen IV, proteoglycans, and cell surface receptors are 
indicated. 
Source:http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=cooper&part=A2035&rendertype=fig
ure&id=A2055
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(1.8) Fibronectin
Fibronectin is a major component of the ECM. Here it exists in an insoluble form, but it 
also exists in plasma and other bodily fluids in a soluble form.
It exists as a dimeric glycoprotein, with subunits of 250 kDa, joined by disulfide bonds at 
one end. Each subunit consists of a series of repeating modules, consisting of 12 type I 
modules, 2 type II modules, 15 to 17 type III modules, and a variable sequence (Figure
1.6). Fibronectin has roles in adhesion, migration, differentiation and proliferation, and is 
therefore important in many physiological processes (Hynes, 1990). Fibronectin is also 
found in the early stages of embryonic development and is critical for normal biological 
development, especially in vascular structures. 
Figure: 1.6.The modular structure of fibronectin. Only one 250 kDa subunit is shown here for 
clarity (taken from Neri & Bicknell, 2005).
Some of the soluble fibronectin may become incorporated covalently into extracellular 
tissues, the rest is synthesized directly into multimeric fibres without being released in a 
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soluble form (Proctor, 1987). This insoluble fibronectin found on cell surfaces and in the 
extracellular matrix has a more structural role and forms the scaffold upon which collagen, 
heparin sulfate, proteoglycans and other ECM components are deposited. Here, it functions 
as an adhesive protein for cell attachment and tissue organization. Fibronectin interacts 
with several kinds of macromolecules, cells and bacteria. Its ability to bind Staphylococci 
was first reported in 1978 by Kuusela, and since then, both gram positive and gram 
negative bacteria have been shown to interact with fibronectin (Proctor, 1988). Fibronectins 
have specific binding sites for binding of collagen, actin, hyaluronic acid, and heparin.
Pankov and Yamada (2002) describe how fibronectin is subject to cell-specific mRNA 
splicing, which results in polypeptide chains differing in the number of internal repeats. 
Plasma fibronectin is synthesized predominantly in the liver by hepatocytes, and shows a 
relatively simple pattern of splicing. On the other hand, cellular fibronectin is much larger 
and produces a large number of variants, resulting in fibronectins with different cell 
binding, ligand binding and solubility properties.
The adhesion of bacteria to fibronectin is believed to represent a significant virulence factor 
for many microorganisms (Joh et al., 1999). Apart from Staphylococci, a number of other 
bacteria have been shown to bind specifically to fibronectin with some of their adhesins 
have been identified (Table 1.4).
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Bacterial Species Protein Reference
Staphylococcus aureus FnbpA & FnbpB Signas et al (1989), 
Johnson et al 1991)
Streptococcus pyrogenes SfbI/ protein F1 Hanski & Caperon (1992),
Talay et al (1993)
Escherichia coli P Fimbriae
Type 1 fimbriae
Westerlund et al (1989, 
1991)
Sokerenko et al (1992)
Campylobacter jejuni Cad F
Flagellin
Konkel et al (1997)
Moser et al (1997)
Adapted from Joh et al., 1999.
(1.9) The Extracellular Matrix
Tissues are composed of biological cells that have a specialized function. The extracellular 
space surrounding cells contains a network of macromolecules known as the extracellular 
matrix. The extracellular matrix (ECM) is composed of a variety of proteins and 
polysaccharides that are secreted locally, and assembled into an organized meshwork
between clusters of cells. These molecules provide the mechanical strength required for 
proper structural support for each tissue, but also provide cells with positional and 
environmental information. The ECM allows information exchange (i.e. signaling) between 
adjacent cells and molecules of the ECM itself. ECM proteins typically have multiple 
domains with specific binding sites for other matrix proteins and for receptors on adjacent 
Table 1.4: Fibronectin binding proteins identified from bacterial species.
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cells, therefore contributing to the organization of the matrix and allowing other cells to 
attach (Alberts, 2007).
While the composition of the ECM can vary in different organs there are many 
macromolecules that are prevalent throughout. There are two main classes of
macromolecules that make up the matrix. Firstly, polysaccharide chains called 
glycocosyaminoglycans (GAG’s), which are usually found covalently linked to a protein 
component in the form of proteoglycans. Secondly, fibrous proteins including collagen, 
elastin, fibronectin and laminan, having both structural and adhesive properties. The 
macromolecules that make up the ECM are mainly produced locally by cells in the matrix. 
The extracellular matrix is not a static structure, in the sense that it is continually being
produced and remodeled, and cell mediated matrix assembly is a highly controlled process 
(Schwarzbauer 1999).
Many bacteria have receptors with specific affinity for components of the ECM. This was 
first recognized by Kuusela (1978) with the discovery of interactions between 
Staphylococcus aureus and fibronectin. Since then it has been shown that several pathogens 
bind components of the ECM, including mucosal pathogens. 
Basement membranes are a specialized type of ECM found underlying epithelial cells. The 
epithelial cell layer consists of cells attached together at several cell junctions, including 
tight junctions, anchoring junctions, and communicating junctions. Beneath the epithelial 
cells is a thin layer of basal laminae or basement membranes containing a framework of 
ECM components. In a normal healthy individual the ECM is not exposed. However, injury 
due to physical or chemical factors can cause a loss of integrity of the ECM, leaving it 
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exposed. This allows bacteria with affinity for ECM proteins, to gain access via the cell 
junctions. They bind to the ECM, facilitating their ability to cause long lasting infection.
Helicobacter pylori penetrates the gastric mucous and binds gastric epithelial cells and 
mucins which allows colonization of the gastric epithelium. After disruption to the 
epithelial cell layer, ECM binding may occur which may have a role in subepithelial tissue 
damage in chronic type B gastritis and gastric duodenal ulcers (Dubreuil et al., 2002, Trust 
et al., 1991).
(1.10) Bacterial Adherance
Adherance: Important for bacterial Colonization and Virulence
To be infectious bacteria need to colonize host tissues they encounter. They do this, in the 
first instance, by means of adhesion using specialized adhesins present on their surface. 
Each bacterial adhesin binds to specific host cell receptors. For molecules to function as 
adhesins they must be presented at the bacterial cell surface and the binding domain must 
be capable of docking with the complementary host cell receptor. Usually, only certain 
regions of the adhesin and receptor are involved in the binding process. Adhesion is a 
critical step in the colonization process. It allows the bacterium to resist removal from the 
host by physical or mechanical forces. Binding to host cell receptors also triggers cellular 
changes such as signal transduction cascades. This leads an inflammatory response where 
infiltration of neutrophils and monocytes occurs, and eventually persistence of the 
bacterium (Testerman et al, 2001). These are called secondary effects of binding.
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However, bacteria have been shown to interact with other host proteins such as serum and 
extracellular matrix proteins, where there is no secondary effect of binding. Kronvall and 
Jonsson (1999) describe how in this case the adhesion has been denoted by a new term 
receptin. Receptins are microbial binding proteins that interact with mammalian target 
proteins.
The main type of surface bacteria encounter are epithelial cells. These include the epithelial 
cells of the skin, upper and lower GI tract and urinary tract which all share the same basic 
characteristics that make up an epithelium; (1) the cells are joined by junctions, (2) the cell 
layer has a free apical surface that may be keratinized or has a mucous layer, (3) beneath 
epithelial cells is a thin layer of basal laminae containing collagens laminans and other 
molecules which make up an extracellular matrix. When the epithelial cell layer loses 
integrity due to physical or chemical forces, bacteria can access these sub-epithelial 
components. Adherence has an especially important role in the colonization of mucosal 
surfaces which are constantly subjected to clearance mechanisms (Odenbreit 2005).
Adherence to host tissue surfaces has been an important factor in the survival of 
microorganisms. Therefore adhesins must have evolved over time as the bacterium has 
evolved, to adapt to new hosts or niches. Many bacterial species are capable of producing 
multiple adhesins, and can alter expression from one adhesive activity to another, and 
modify the strength of binding by means of antigenic variation. This can help the bacterium 
overcome host immune recognition, but, of course, makes vaccine development targeting 
specific adhesins difficult.
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(1.11) Helicobacter Pylori binding to ECM
A large number of microorganisms have been shown to adhere to the mammalian Extra 
Cellular Matrix (ECM) (see Table 1.5) and that adherence has been shown to contribute to 
their virulence (Patti & Hook, 1994) and (Westerlund & Korhonen, 1993).  H. pylori has 
been shown to adhere specifically to several proteins in the extracellular matrix (see
Dubreuil et al., 2002 for review) including laminin and collagen IV, vitronectin and heparin 
sulphate (Trust et al., 1991, Valkonen et al.,1993, Moran et al., 1993). Expression of 
receptins may only appear at certain phases of bacterial growth, for example H. pylori only 
expresses ECM-binding molecules at the stationary phase of growth, and for specific ECM 
molecules it was shown that both coccoidal and spiral forms of the organism express 
similar ECM binding patterns (Khin et al., 1996).
Several ECM receptins have been identified for H. pylori (see Table 1.6). Laminan has a 
high carbohydrate content, mainly complex oligosaccharides, therefore binding to 
microorganisms has been found through lectin interactions (Ljungh et al., 1996). Laminin 
binds H. pylori via surface proteins (Valkonen et al., 1993 and Valkonen et al., 1994). 
Trust et al., (1991), showed that binding of H. pylori to laminin was rapid (15-30 mins), of 
high affinity Kd = 7.9nM and partially reversible. The binding interaction involves bacterial 
receptins recognizing certain sialylated oligosaccharides of the glycoprotein. 
Hemagglutinating strains have shown enhanced binding of laminin compared to non 
hemagglutinating strains (Valkonen et al., 1994). A H. pylori 25 kDa outer membrane 
protein which acts as a lectin-like molecule was identified as a laminin binding protein 
(Valkonen et al., 1997), and another interaction between laminin and H. pylori has been 
proposed to be mediated by lipopolysaccahrides (Valkonen et al., 1994). 
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Collagen receptin Staphylococcus aureus
Staphylococcus lugdunensis
Streptococcus pyogenes
Streptococcus pneumoniae
Escherichia coli
Helicobacter pylori
Aeromonas salmonicida
Treponema pallidum
Yersinia pestis
Fibrinogen receptin Staphylococcus aureus
Staphylococcus lugdunensis
Streptococcus pyogenes
Streptococcus agalactiae
Streptococcus canis
Porphyromomas intermedius
Porphyromonas gingivalis
Fibronectin receptin Staphylococcus aureus
Staphylococcus hyicus
Streptococci, grp A, C, G
Streptococcus equi subsp. Zooepidemicus
Streptococcus, a-hemolytic
Porphyromonas gingivalis
Neisseria meningitides
Treponema pallidum
Mycobacterium tuberculosis
Mycobacterium paratuberculosis
Lactoferrin receptin Staphylococcus aureus
Escherichia coli
Neisseria gonorrhoeae
Aeromonas hydrophila
Porphyromonas gingivalis
Prevotella intermedia
Laminin receptin Staphylococcus aureus
Streptococcus pyogenes
Streptococcus pneumoniae
Escherichia coli
Treponema pallidum
Actinobacillus actinomycetemcomitans
Plasminogen/plasmin receptin Staphylococcus aureus
Streptococcus pyogenes
Streptococci, grp C, G
Table 1.5. Some bacterial receptins with binding sites for mammalian proteins
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Streptococcus equisimilis
Streptococcus pneumoniae
Haemophilis influenzae
Moraxella eatarrhalis
Escherichia coli
Proteus mirabilis
Pseudomonas aeeruginosa
Neisseria gonorrhoeae
Neisseria meningitides
Borrelia burgdorferi
Yersinia pestis
Vitronectin receptin Staphylococcus aureus
Streptococci, grp A, C
Streptococci, grp C, G
Streptococcus grp G
Streptococcus pneumoniae
Escherichia coli
Neisseria gonorrhoeae
Helicobacter pylori
Table adapted from Kronvall and Jonsson 1999.
The ECM glycoprotein plasminogen is a 90 kDa single chain pro-enzyme in its native 
form. Plasminogen binding to H. pylori is a common CagA independent phenomenom 
among H. pylori strains, and generally independent of the morphological state, spiral or 
coccoid, of the bacteria (Ringner et al., 1994). H. pylori CCUG 17874 interacts with the 
fifth kringle of the plasminogen molecule through two surface proteins of 42 and 57 kDa 
(Pantzar et al., 1998). Cell surface bound plasminogen is easily activated to plasmin – an 
enzyme that dissolves fibrin in blood clots. This activation of plasmin is a common 
mechanism used by certain invasive bacteria to facilitate movement through tissue barriers 
(Lottenberg et al., 1994). It has been suggested that H. pylori bound plasmin may be a 
Table 1.5. Continued
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mechanism to degrade the extracellular matrix, which could delay the healing of gastric 
ulcers (Pantzar et al., 1998).
Pantzar et al., (1998), also identified a 57 kDa vitronectin binding protein using a surface 
protein extract immunolblot assay. The 57 kDa vitronectin binding protein had an amino 
terminal amino acid sequence identical with the amino-terminal of H. pylori catalase. 
Although catalase is normally a cytoplasmic protein, it is thought that it may become 
associated with the cell surface when cells undergo autolysis (Phadnis et al., 1996), or 
through a specific transport mechanism (Vanet and Labigne 1998). Pantzar et al., suggested
both of these hypotheses to explain surface location of proteins that are normally 
cytoplasmic, and therefore the possibility that catalase might function as an adhesin that 
binds vitronectin.
Other binding proteins have been identified for heparin and heparan sulfate - 47, 66 and 71 
kDa proteins and  the 58 kDa subunit of VacA cytotoxin (Ascencio et al., 1993,
Ruiz-Bustos et al., 2000 and Utt et al., 2001). The techniques for ECM receptin 
identification include radiolabelling, OMP isolation, and 2D gel analysis. Another method 
that has been used for receptin identification is affinity chromatography, where the 
sepharose is coupled to the ECM protein of interest and a bacterial cell lysate is applied to 
this resin in a chromatography column.
ECM Protein Receptin Reference
Laminin LPS, 25 & 67 kDa proteins Trust et al., 1991.
Valkonen et al., 1994 & 
1997.
Table 1.6: Helicobacter pylori ECM Receptins 
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Heparin & Heparan sulfate 47, 66 and 71 kDa proteins
58 kDa subunit of VacA 
cytotoxin
Ascencio et al., 1993.
Ruiz-Bustos et al., 2000.
Utt et al., 2001.
Plasminogen & Plasmin 42, 57 and 58.9 kDa 
proteins
Pantzar et al., 1998,
Ringner et al.,
Fibronectin and Fibrinogen Not Identified Trust et al., 1991.
Vitronectin 57kDa protein Pantzar et al., 1998.
Collagen IV Not Identified Trust et al., 1991.
Khin et al., 1996.
(Table 1.6. Adapted from Dubreuil et al., 2002).
(1.12) Implications for therapy
The ECM binding bacterial adhesins can be used as vaccine candidates in an anti-adhesin 
vaccine. With the increasing prevalence of antibiotic-resistant strains of bacteria, this new 
approach could provide a promising alternative treatment. Potential targets for the 
development of new strategies could include subunit vaccines or receptin blockers. These 
strategies could however be complicated by the fact that environmental factors can affect 
expression of these genes or by the fact that not all adhesin genes are present in all strains. 
Because microorganisms can have several mechanisms of adhesion to colonize and infect 
host tissues, anti adhesion drugs may have to be composed of a cocktail of inhibitors. 
Targeting therapy against microbial interactions with ECM components could also prevent 
deep tissue infections as it is believed that H. pylori gain access to the subepithelial layer by 
means of ECM receptins on their surface.
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For H. pylori, interactions with certain host ECM proteins are of high affinity and cannot be 
ignored as possible pathogenicity attributes. When adherent to animal cells or tissues 
bacteria acquire greater resistance to normal immune responses and antibiotics and are 
better able to gain nutrients. The possibility that a bacterium can coat itself in ECM proteins 
to evade immune recognition initiates and permits lifelong infection.  It has been proposed 
that interactions of H. pylori and ECM proteins represent a mechanism of adherence to 
gastric tissue thereby playing a role in development of chronic B gastritis and peptic ulcer 
disease (Ringner et al., 1994). Moreover, the iron acquisition system of H. pylori by using 
the human lactoferrin receptor system may play a role in the virulence of H. pylori infection 
(Husson et al., 1993). 
For certain microorganisms receptins binding to host proteins have been shown to 
contribute to virulence in animal models. Staphylococcus aureus produces a variety of cell 
wall associated proteins that interact with ECM proteins of the host. S. aureus binding 
ECM binding proteins such as fibronectin, fibrinogen and collagen have been investigated 
as components of vaccines to protect against S. aureus infections in laboratory animals. 
Mamo et al (2000) reported that mice vaccinated with a combination of two S. aureus
antigens consisting of a recombinant collagen binding protein (CnBP) and alpha-toxoid 
were significantly protected from intramammary challenge infection with S. aureus. The 
average number of bacteria recovered from the glands of mice vaccinated with a 
combination of CnBP/alpha-toxoid was significantly lower compared to the average 
number of bacteria recovered from the glands of mice vaccinated with only CnBP or alpha-
toxoid or controls. 
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Schennings et al (1993) prepared a fusion protein by cloning the lacZ gene encoding beta-
galactosidase(gal) in frame with a region of the S. aureus fibronectin binding protein fnbA. 
Rats were immunized with the gal-FnBP in Freund’s adjuvant and the resulting antibodies 
blocked the in vitro binding of S. aureus to immobilised fibronectin. 
Mice immunised with gal-FnBP (with Freund’s adjuvant) showed fewer cases of severe 
mastitis than control mice (immunized with adjuvant alone) and fewer bacteria were 
recovered from the mammary glands of vaccines than from those of control mice (Mamo et 
al., 1994).
Another study revealed that heparin as well as polysulphated agents, inhibited binding of 
fibronectin, vitronectin and lactoferrin by S. aureus (Pascu et al., 1995). These could 
provide alternatives to antibiotic therapy for treatment of S. aureus infected wounds and 
superficial infections.
Another benefit of understanding microbial interactions with the ECM could prove useful 
in the area of biomaterials where devices are implanted into patients. Infection of these 
biomaterials can give rise to serious complications especially in tissue penetrating devices. 
Host proteins absorb onto the biomaterial surface and when bacteria come into contact with 
the surface they can bind to the adsorbed proteins. Fibronectin and fibrinogen have been 
proposed to mediate adhesion of bacteria to these devices (Vaudaux et al., 1993 and 
Herman et al., 1991) as well as vitronectin (Fabrizus-Homan & Cooper, 1991). Treatment 
of these infections has been reported to be almost impossible (Gristina, 1987). Therefore 
preventative measures that block adhesion may be a useful tool to overcome these 
problems.
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Although this thesis has mainly focused on pathogenesis of ECM binding, it is worth noting 
that many probiotic bacteria also bind to the ECM and a lot of research has been carried out 
on this area also to date. For example Lactobacilli bind to immobilised collagen and 
fibronectin (Lorca et al., 2002) and Styriak et al (2003) report probiotic bacteria binding to 
ECM molecules. Probiotics have many beneficial effects in various food matrices and 
milks as well as having a role in the prevention of gastrointestinal infections (Nemcova et 
al., 1998, Alvarez-Olmos & Oberhelman, 2001). Probiotic bacteria have the potential to 
prevent attachment of pathogens such as E. coli and H. pylori to mucosal surfaces by 
colonising the surfaces and blocking attachment (Lee et al., 2000, Mukai et al., 2002). As 
probiotic strains bind the ECM, they should be able to compete with pathogens for the 
same receptors and to occupy their binding sites (Neeser et al., 2000).This research into the 
area of probiotic bacteria interacting with ECM molecules could prove useful for probiotic 
applications but also in the treatment or prevention of infectious gastrointestinal bacteria for 
example H. pylori.
(1.13) Aims and objectives of project.
This project attempts to identify collagen binding adhesins on Helicobacter pylori. Such 
adhesins are possible targets for therapeutic intervention. For example ECM binding 
proteins may represent potential targets for the development of novel antimicrobial agents, 
including vaccines and adhesion blockers. Despite indications of specific binding no 
Collagen IV binding protein has been identified in H. pylori to date.
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The potential benefits of identifying the Collagen receptin in H. pylori are many:
 Interactions of bacteria with the ECM are thought to be of pathogenic significance, 
therefore possibly adding to the understanding of pathogenesis.
 Knowledge of the molecular basis of adherence.
 Aid in the development of novel antimicrobial therapies, including vaccines.
 Binding to Collagen may equip the bacterium with a mode of immune system
evasion, as well as contributing to deep tissue invasion and persistence in the host.
The approach adopted in this work was to use the ReTagging Method in order to isolate
Helicobacter pylori collagen IV binding proteins. Binding of H. pylori to ECM proteins 
was first confirmed using a bacterial overlay dot blot method. Once this was confirmed a
ReTagging Method was employed in an attempt to identify the collagen binding protein. A 
variety of methods of fractionation of H. pylori proteins was examined in an attempt to 
circumvent difficulties with non specific binding.
Finally an H. pylori outer membrane fraction was probed using a receptor overlay 
immunoblot technique in a further attempt to identify a collagen IV receptin.
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Chapter 2
Materials & Methods
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(2.0) Materials and Methods
(2.1) Reagents
Bovine serum albumin, acrylamide:bisacrylamide (29:1), ammonium persulphate, β-
mercaptoethanol, sodium chloride, sodium hydroxide, magnesium chloride, potassium 
chloride, Tris(hydroxylmethyl)aminomethane (Tris), glycine, TEMED, Tween-20,
Dimethyl sulfoxide and sodium dodecyl sulphate were obtained from Sigma Aldrich.
Brain Heart Infusion Medium was obtained from GIBCO BRL (Life Technologies, 
Scotland). Ethanol, methanol, glacial acetic acid, orthophosphoric acid, hydrochloric 
acid and glycerol were obtained from BDH Ltd. (Poole, Dorset, UK).
All buffer reagents for SDS PAGE were prepared in deionised water (Elga Prima 
reverse osmosis). 
(2.2) SDS Polyacrylamide Gel Electrophoresis and Western
Immunoblotting
(2.2.1) Sample and Molecular weight standards preparation
Protein samples were resuspended in 1x reducing sample buffer for loading onto gels
(see Apendix A) unless otherwise stated. Bacterial pellets were resuspended in 2x 
reducing or non reducing sample buffer unless otherwise stated. For concentration of 
proteins, a TCA precipitation method was used. TCA was added to the protein sample
to 13% of the final volume and stood at 4˚C for at least 30 minutes. The precipitated 
protein was removed by centrifugation at 15,000 rpm at 4˚C for 5 mins, and the 
supernatant was removed by aspiration and discarded. The pellet containing the 
precipitated protein was resuspended in 2x reducing sample buffer. All protein samples, 
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along with molecular weight standards, were boiled for 5 minutes at 100˚C, prior to 
loading onto an SDS gel.
(2.2.2) SDS-PAGE
An ATTO system was used for SDS-PAGE gels (ATTO Corporation, Japan). 
Electrophoresis was carried out using a Consort electrophoresis power supply unit.
Proteins were separated on reducing gels, with a discontinuous buffer system using the 
method of Laemmli (1970) as adopted by Sambrook et al (1989). Resolving and 
stacking acrylamide gels were prepared to the percentage of required acrylamide as 
indicated in Tables 2.1 and 2.2 below. 
Either APS or TEMED were added last for polymerisation of the gel. Electrophoresis 
was carried out at 25mA per gel for approximately 1.5 hours, or until the tracking dye 
had reached 5mm above the gel base, at which stage electrophoresis was terminated.
Table 2.1: Solutions for preparing Resolving Gels for SDS-Polyacrylamide Gel 
Electrophoresis.
% Acrylamide
Component 8% 10% 12%
H2O 9.3ml 7.9ml 6.6ml
Acryl/Bis 30% 5.3ml 6.7ml 8.0ml
1.5M Tris pH 8.8 5.0ml 5.0ml 5.0ml
10% SDS 200µl 200µl 200µl
10% Ammonium 
Persulfate
200µl 200µl 200µl
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TEMED 12µl 8µl 8µl
Table 2.2: Solutions for preparing stacking gels for SDS-Polyacrylamide Gel 
Electrophoresis.
Component Volume
H2O 3.4ml
Acryl/Bis 30% 830µl
1M Tris pH 6.8 630µl
10% SDS 50µl
10% Ammonium Persulfate 50µl
TEMED 5µl
(2.2.3) Western Immunoblotting
Western Immunoblotting was carried out using the semi-dry method of transfer of 
electrophoresed proteins to immobilising membranes as described by Towbin (1979) 
and was performed using an ATTO semi-dry transfer system (ATTO Medical Supplies , 
Japan). Prior to transfer Polyvinylidene fluoride (PVDF) transfer membrane of 
dimensions 6.5 x 9 cm was wetted in methanol for 10-15 seconds and then equilibrated 
in transfer buffer (See Apendix A for composition). Whatmann 3 MM filter paper was 
also soaked in transfer buffer prior to semi dry blot sandwich construction, which was 
assembled in the order of cathode, filter paper, PVDF membrane, acylamide gel, filter 
paper and finally anode. Electrophoretic transfer was performed at 100 mA per gel for 
60 minutes. Unless biotinylated molecular weight markers or prestained markers were 
included,  the lane containing the molecular weight markers was stained with
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Coomassie Blue R-250, followed by destaining in a destain solution containing 
methanol, water and acetic acid (See Apendix A for composition). 
(2.2.4) Immunoblot detection and development
Following semi-dry transfer, non-specific sites on the PVDF membrane were blocked 
by incubation with freshly prepared TBS buffer containing 5% skimmed dried milk 
(Blocking solution) for one hour with gentle rolling on a roller mixer (Stuart Scientific, 
UK). Blots were incubated for 2 hours with primary antibody diluted 1:1000 in antibody 
diluent. Following incubation with primary antibody, membranes were washed 3 times, 
for 10 minutes each with TBS-Tween (0.1%) washing buffer. Membranes were then 
incubated with the relevant horseradish peroxidase-conjugated  secondary antibody in 
diluent solution (See Apendix A) for 1 hour at room temperature on a roller mixer 
(SRT6, Stuart Scientific).  For detection of biotinylated proteins, membranes were 
incubated with horseradish peroxidase-conjugated secondary antibody diluted 1:1000 in 
Antibody diluent solution. Following incubation with secondary antibody, blots were 
finally washed 3 times for 20 minutes each, with TBS-Tween (0.1%) pH 7.4 washing 
buffer. 
Development of Immunoblots was carried out using the enhanced chemiluminescence 
(ECL) method. Membranes were incubated for 1 minute in ECL Western Blotting 
Detection Reagents (Amersham). The membrane was removed and placed between 
acetate sheets, which were then exposed to Kodak film for the appropriate time period 
(range 1 min to 10 mins). Exposed films were developed using an automatic developer 
(CURIX 60, AGFA, Type 9642/100/140, Agfa-Gevaert AG, Munich, Germany).
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(2.3) Binding of Helicobacter pylori to ECM proteins using a Dot Blot 
Method
(2.3.1) Bacterial strains and growth conditions
Helicobacter pylori SS1 were grown for 48 hours on Columbia agar plates 
supplemented with 10% horse blood serum at 37°C in a microaerobic (Anoxomat)
atmosphere generated using a MART Microbiology Anoxomat system (Lichtenvoorde, 
the Netherlands). For liquid culture, strains were grown in Brucella broth or Brain Heart 
Infusion medium supplemented with 7% fetal bovine serum, in a microaerobic 
atmosphere, at 37˚C and 120rpm in an orbital incubator (S1 50, Stuart Scientific). For 
iron reduced conditions 100μm desferroxamine was added to the medium.
(2.3.2) Labelling H. Pylori with FITC (fluorescein isothiocyanate)
2 days after inoculation, bacteria were removed from the agar plate with a sterile loop 
and resuspended in 1ml 0.15M NaCl, 0.1M sodium carbonate, pH 9.0, by gentle 
pipetting. 10µl of a 10mg/ml FITC solution in dimethyl sulfoxide (freshly prepared) 
was added into the cell culture suspension and incubated for 30 minutes at room 
temperature in the dark. Bacteria were centrifuged at 3000g (5700rpm) for 5 minutes
and resuspended in 1ml PBS by gentle pipetting. The wash cycle was repeated 3 times. 
Aliquots were used immediately or stored at -20°C for further use.
(2.3.3) Extracellular Matrix (ECM) Proteins
ECM proteins used were Laminin (Mouse 1, Cultrex, Trevigene), Fibronectin (from 
Human Plasma, Sigma), Collagen IV (from Engelbreth Holm Swarm Sarcoma, Sigma), 
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Lactoferrin (Sigma), HSA (Sigma), Hemin, HSA:Hemin complex. BSA (Sigma) was 
included as a negative control.
(2.3.4) Preparation of HSA:Hemin Complex
Hemin was dissolved at 10mM in DMSO immediately before use in a foil wrapped 
microcentrifuge tube. Hemin and HSA solutions were mixed to give a molar ratio of 1.1 
: 1.0. The mixture was incubated with constant rotation, at room temperature overnight 
for at least 12 hours. The tube was protected from light.
(2.3.5) Bacterial Overlay Method (Dot Blot)
This overlay method was performed essentially as described by Ruhl et al., (2000) and 
adapted by Walz et al., (2005) where fluorescence labelled bacteria were used as 
probes. PVDF membranes were first wet in methanol followed by TBS buffer. 
Membranes were then transferred to a moist chamber to prevent drying. PVDF 
membranes were spotted with 5µl volumes of ECM proteins at 1mg/ml. Membranes 
were blocked for one hour at room temperature in Blocking buffer (50mM Tris pH7.5; 
150mM NaCl, containing 5% BSA, 1mM MgCl2, 1mM CaCl2 ). 1ml of  fluorescein 
labelled bacterial suspension was added to the membrane and sealed in a bag. The 
overlays were incubated with labelled bacteria for 30 minutes at 4°C in the dark without 
mixing, and washed on a rotary shaker (Stuart Scientific, UK) for 3 x 5 minutes in TBS-
T containing 1mM MgCl2, 1mM CaCl2. The membranes were protected from light 
throughout. The fluorescence of adherent bacteria was visualised using a UV light
source (10 W).
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(2.4) Identification of Collagen IV binding proteins using Sulfo-SBED 
Biotin Label Transfer Kit 
In this work we attempt to identify the collagen IV receptor by use of direct binding 
measurements and Tagging Technology. The tagging method was adapted from Ilver et 
al 1998, using a Receptor Activity- Directed Affinity Tagging method called 
“Retagging” (Figure 2.1).  This technique employs an ECM protein covalently attached 
to a multifunctional crosslinker, which, following UV irradiation and reduction, 
transfers a biotin tag to the cognate adhesin (or receptin) on H. pylori.  The adhesin is 
then identified by Western Blot analysis using streptavidin tagged Horeseradish 
peroxidase (HRP).  After detergent solubilisation, the adhesin may be isolated from cell 
suspensions by use of streptavidin coated magnetic beads. The beads provide a method 
to affinity purify adhesion proteins labelled by the tagging technique. A kit for 
retagging of proteins is commercially available from Pierce Chemicals.
Thus, in step 1 collagen is covalently attached to the tag by modification of a surface 
amino acid on collagen with the tag’s N-hydroxysuccinimide (NHS) moiety. NHS 
esters react with primary amines on protein side chains at pH 7-9 to form covalent 
amide bonds. In step 2, collagen with its attached tag is incubated with H. pylori cells 
where the collagen binds to the H. pylori adhesin (putative). In step 3 exposure to UV 
light causes activation of the aryl azide group causing it to react with amino acid 
residues on proteins adjacent to the bound collagen. In step 4 Collagen is removed by 
reduction of a disulfide bond that links the NHS moiety of the tag to the modified 
collagen amino acid. The result is that the protein adjacent to bound collagen becomes 
labelled with a biotin tag. This protein is assumed to be the receptin/adhesin for 
collagen. The biotin labelled protein may subsequently be identified following 
separation by electrophoresis (or a similar method) and probing with sterptavidin HRP.
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The numerous steps in this tagging method and the requirement to carry out a series of 
tagging reactions in sequence can potentially give rise to problems and great care is 
required in preparation and handling of reagents.
(2.4.1) Labelling of Bait Protein usingProfound Sulfo-SBED Biotin 
Label Transfer Kit (Pierce)
The manufacturer’s instructions for use of this labelling kit were followed. A brief 
description of the process is given below.
Collagen IV (from Engelbreth Holm Swarm Sarcoma, Sigma) was diluted to give 
200μg/ml in PBS (Pierce Kit) adjusted to pH 8.0. The collagen was labelled using 
manufacturers guidelines for the kit. Sulfo-N-hydroxysuccinimidyl-2-(6-[biotinamido]-
2-(p-azido benzamido)-hexanoamido) ethyl-1,3'-dithioproprionate (Sulfo –SBED)
labelled protein was divided into single-use aliquots and stored protected from light at -
80C. Label incorporation was assessed by performing a dot blot using Streptavidin-
HRP as a probe. Briefly, a few microlitres of labelled collagen were spotted onto one 
side of a PVDF membrane along with unlabelled collagen for use as a control. The 
membrane was blocked by washing with a skimmed milk powder solution (PBS 
containing Marvel, 5%, w/v) and probed with streptavidin HRP which reacts 
specifically with biotin.
(2.4.2) Identification of Collagen Binding Proteins from H. pylori using 
ProFound Sulfo SBED Biotin Label Transfer Kit
H. pylori SS1Rf were grown for 48 hrs on Columbia agar plates. Bacteria were 
harvested from the agar plate and resuspended in 1 ml PBS (supplied with Pierce Kit),
washed twice in PBS and adjusted to an OD600 of 1.0. SBED-labelled protein was added 
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to the bacterial suspension and incubated under microaerophillic conditions for 1hr at 
room temperature and protected from light. This exposure initiated the reaction between 
the aryl azide moiety of the tag and the putative collagen receptor(s). 
The suspension of bacteria with the collagen-crosslinker conjugate was mixed every 15 
minutes. Samples were transferred to a 96 well plate and the SBED conjugate was 
photoactivated using a UV light source for 10 minutes at a distance of 5 cm. Samples 
were removed to minifuge tubes and centrifuged for 3 minutes at top speed. Pellets were
resuspended in sample buffer and 
DTT at a concentration of 100mM was added to samples that required complete 
disulfide bond reduction. Samples were boiled for 5 minutes at 100°C. Proteins were 
separated by electrophoresis and probed with streptavidin-HRP. Each sample was 
loaded on the electrophoresis gel under reducing conditions. A control for each sample 
was loaded under non reducing conditions. Reducing conditions (the final concentration 
of DTT must be 100mM for complete disulfide bond reduction) resulted in the cleavage 
of the disulfide bond on the crossslinker.
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Aryl 
azide
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bond
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Collagen-cross-linker conjugate
Collagen IV
A
modified from Ilver et al., 1998; Science 279: 373-377
B
Collagen IV
Collagen-binding activity
Collagen IV 
receptor
Helicobacter pylori
C UV cross-linking
Collagen IV
Helicobacter pylori
Reducing conditions
Collagen IV
D
Helicobacter pylori
Figure 2.1: Overview of Retagging Method for purification of collagen IV binding protein. 
(A) The Sulfo-SBED crosslinker has an NHS group for conjugation to collagen IV, a central 
disulfide bond, a photoreactive arylazide group and a biotin side group. (B) The Collagen 
labelled with crosslinker is incubated with Helicobacter pylori, bringing the crosslinker close to 
the adhesin protein. (C) The cells are exposed to UV light, causing the photoreactive sidegroup 
to form a covalent bond to the adhesin protein. (D) Reducing conditions result in the cleavage of 
the disulfide bond in the cross linker. Collagen IV is subsequently released and washed away. 
The end result is that the adhesin is labelled with biotin.
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(2.4.3) SDS - Polyacrylamide gel electerophoresis and Western Blot 
Analysis
Samples were applied to a 10% polyacrylamide gel and transferred to a PVDF 
membrane. Membranes were blocked in 5% Skimmed Milk Powder in TBS and 
incubated with Streptavidin HRP (1:2000 dilution) for at least 1 hour. 
(2.4.4) Purification of biotinylated proteins using streptavidin coated 
magnetic beads
MyOne Streptavidin T1 Dynabeads (Invitrogen), were prepared as described by the 
manufacturer. Beads were incubated with biotinylated proteins in Lane Marker 
Reducing Sample Buffer (Thermo Scientific) for 30 minutes at room temperature using 
gentle rotation. Protein coated beads were separated using a magnetic rack for 2-3 
minutes and beads were washed 5 times in PBS and resuspended in sample buffer. The 
biotin-streptavidin bond was broken by boiling the samples for 5 minutes. Samples were 
loaded on a 12% polyacrylamide gel and transferred to a PVDF membrane.
(2.4.5) Coomassie Blue G-250 staining (for Mass Spectrometric analysis)
The SDS gel was rocked overnight in fixation solvent (50 % methanol, 2 % phosphoric 
acid, 85 %), washed 3 times in 500 ml water followed by shaking for one hour in 
incubation solvent (34% methanol, 2% phosphoric acid, 85%, 17% ammonium 
sulphate). Coomassie G-250 (Bio-rad) solution was added to the incubation solvent 
(0.025% Coomassie G-250 in 20ml methanol) to give 0.25g/L incubation solvent. 
Staining was for 2-3days, followed by washing in water then washing twice in 25% 
methanol. The Gel was washed in water and sealed at stored at 4 ºC. The gel was 
visualised and stained protein bands were excised for mass spectrometric analysis.
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(2.4.6) Purification of H. pylori Catalase
Helicobacter pylori SS1 were grown for 48 hours on Columbia agar plates 
supplemented with 10% horse blood serum in a microaerobic (Anoxomat) atmosphere 
at 37°C. Bacteria were harvested by suspension in 25mM sodium phosphate buffer pH 
7.5. After centrifugation the pellets were resuspended in buffer and sonicated for 8 x 30 
second intervals, keeping samples on ice throughout. Cellular material was removed by 
centrifugation at 10,000g for 5 minutes at 4°C. The supernatant was collected and 
filtered through a 0.22µm-pore-size filter. Extracts were kept on ice throughout.
The filtrate was loaded onto an ion exchange column (Resource S, 1ml, GE Healthcare) 
equilibrated in 25mM sodium phosphate buffer, pH 7.5.
Proteins were eluted by gradient of 0-1M NaCl in 25mM sodium phosphate buffer pH 
7.5. Catalase positive fractions were selected by checking oxygen reducing activity in
the presence of 3% H202. The purity of catalase was confirmed by Sodium Dodecyl 
Sulphate-Polyacrylamide Gel Electrophoresis (SDS PAGE,12% polyacrylamide).
The fractions collected were stored at 4ºC and were stable at this temperature for several 
days.
(2.4.7) Gel Filtration analysis of Collagen and H. pylori Catalase to 
check for binding activity
Gel filtration was performed using a Superdex 200 gel filtration column equilibrated in 
PBS buffer pH 8.0 using an AKTA FPLC system (Amersham Pharmacia, UK). A 
standard curve was constructed using molecular weight standards. Collagen and H. 
pylori catalase were applied separately to the column and the volume at which each 
protein was eluted was noted. A collagen and H. pylori catalase mixture, incubated for 
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half an hour on ice, was applied to the column and elution point noted. The flow rate in 
all cases was 0.4ml/min.
(2.4.8) Binding assay to test for Collagen IV binding to H. pylori Catalase
A 96 well plate was coated with collagen IV at concentrations of 100, 50 and 10 µg/ml 
and left overnight at 4°C. PBS was used as a control. Excess liquid was removed from 
the plates and they were blocked for one hour in 5% BSA at room temperature. Excess 
liquid was removed and 100µl H. pylori catalase was added and incubated for one hour 
at room temperature. The plate was washed with PBS buffer three times. 100 µl PBS 
was added and 3% hydrogen peroxide was used to test for catalase activity.
(2.5) Identification of Collagen IV binding proteins using Immunoblot 
Methods.
(2.5.1) Preparation of H. pylori Outer Membrane Protein Fraction
Helicobacter pylori SS1 were grown for 48 hours on Columbia agar plates 
supplemented with 10% horse blood serum in a microaerobic (Anoxomat) atmosphere 
at 37°C. Cells were harvested and washed three times (4,000rpm, 10 minutes) with 
20mM Tris-HCl, pH 8.0. Cells were sonicated on ice (8 times for 30 seconds, intervals 
of 1 minute). Unbroken cells and debris were removed by centrifugation (4,000rpm, 10 
minutes, 4°C). The supernatants were ultracentrifuged at 45,000g for 20 minutes at 4°C, 
and pellets were washed three times with 20mM Tris-HCl, pH 8.0. A bicinchoninic acid
(BCA) protein assay (Thermo Scientific Pierce) was carried out to determine the protein 
concentration. The pellets were resuspended in 0.6% N-lauroyl sarcosine-20mM Tris-
HCl, pH 8.0 to a final concentration of 1mg of protein/ml and incubated at room 
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temperature for 20 minutes. Outer membrane proteins were collected by 
ultracentrifugation at 45,000g for 20 minutes at 4°C.
The sarcosine insoluble pellets were dissolved in 20mM Tris-HCl, pH 8.0 for protein 
determination. Supernatants containing sarcosine soluble fraction were retained.
For SDS-PAGE, samples were TCA precipitated to yield a concentration of 100µg of 
protein per lane. The OMP fraction is insoluble in sarcosine, whereas the cytoplasmic 
fraction is totally soluble. 100µg of each protein fraction, as well as a whole cell extract 
were TCA precipitated and resuspended in 2X reducing sample buffer.
(2.5.2) Outer Membrane Protein immunoblot
100µg of Outer membrane proteins were TCA precipitated and resuspended in 2X 
reducing sample buffer. Samples were boiled for 5 minutes and loaded onto a 12% 
polyacrylamide gel and run for 1 hour and 20 minutes at 25mA. Proteins were 
transferred to PVDF membrane for 1 hour at 100mA. Membranes were blocked for one 
hour in 5% skimmed milk powder in TBS-T. Membranes were then incubated with 
Collagen IV, X-linked Collagen IV or X-linked Fibronectin, at concentrations of 
20µg/ml for 2 hours. Collagen IV and X-linked Collagen IV were diluted in PBS pH 
8.0, and Fibronectin was diluted in PBS, pH 7.2. Membranes were washed for 3 x 5 
minutes in TBS-T. Membranes treated with X-linked Collagen and X-linked 
Fibronectin were probed with Streptavidin-HRP (Pierce) (1:1000 dilution), for one 
hour, and washed for 3 x 20 minutes with TBS-T.  Membranes treated with Collagen IV 
were probed with Rabbit Anti Collagen IV (Acris Antibodies) for 2 hours, washed 3 x 
20 minutes with TBS-T, and probed for one hour with Goat anti Rabbit HRP (Santa 
Cruz Antibodies).  It was expected that collagen would bind directly to its H. pylori 
adhesin on the PVDF membrane and that this interaction could be observed by probing 
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with antibodies. We hoped that by using this method we could overcome some of the 
possible problems encountered with the crosslinker such as non-specific binding, and 
the potential of the crosslinker to attach to proteins other than the collagen adhesin 
protein.
48
Chapter 3
Results
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(3.0) Results
(3.1) Introduction
Various investigations have revealed that many microorganisms interact with the
mammalian extracellular matrix, and have shown the importance of these interactions
for pathogenicity. H. pylori is known to interact with a number of Extracellular Matrix
(ECM) components such as laminin and plasminogen. Some reports have suggested that
collagen IV interacts with H. pylori but an adhesin for this ECM protein has not been
identified. Identification of a collagen IV receptor could yield benefits for the treatment
of H. pylori infection. For example, such receptors may represent potential targets for
the development of novel antimicrobial agents, including vaccines and adhesion
blockers.
(3.2) Binding of Collagen and ECM proteins to H. pylori cells.
 (3.2.1) Labelling H. pylori with FITC (fluorescein isothiocyanate)
H. pylori was labelled using fluorescein isothiocyanate (FITC) as described in Materials
and Methods (Section 2.3.2). Labelling was verified by visualisation of green
fluorescence of cells by microscopy (data not shown).
(3.2.2) Bacterial Overlay Method (Dot Blot)
H. pylori labelled with FITC were applied to PVDF membranes spotted with ECM
proteins. The ECM proteins used were laminin, fibronectin, collagen IV, lactoferrin,
HSA:hemin complex, HSA and hemin. It is important to note that hemin is dark in
colour and could therefore be seen as a dark spot after applying onto the membrane.
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BSA was used as a control. In all cases binding was observed to laminin, fibronectin
and collagen IV(Figures 3.1, 3.2, & 3.3).
(3.2.3) Assessment of H. pylori Binding to ECM Proteins under Different
Growth Conditions.
Changes in growth conditions are known to affect expression of adhesins. We examined
collagen binding under different growth conditions.
Binding of H. pylori was assessed under the following growth conditions - directly from
agar plates (Figure 3.1), from liquid culture (Figure 3.2.) and from liquid culture under
iron reduced conditions using the iron chelator desferroxamine (See Fig. 3.3).
Binding of H. pylori to ECM proteins was observed under the three growth conditions
examined. This experiment clearly showed binding of H. pylori to the ECM proteins
collagen IV, laminin and fibronectin. Under the same conditions H. pylori did not bind
to lactoferrin, HSA, HSA:hemin complex hemin, or the control BSA.
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Figure 3.1. Bacterial Overlay: The adhesion of fluorescein-5-isothiocyanate (FITC) –
labelled H. pylori to ECM proteins. ECM proteins were spotted onto PVDF membranes and
overlaid with FITC labelled bacteria. Adherent bacteria were visualised under UV light. This
shows H. pylori labelled from an agar plate. L = Laminin, F = Fibronectin, C = Collagen IV,
LF = Lactoferrin, HSA:H = HSA Hemin complex, HSA = Human Serum Albumin, H =
Hemin, and BSA was used as the control. The green fluorescence is observed as white spots on
the membranes shown above.
Figure 3.2. Bacterial Overlay: The adhesion of fluorescein-5-isothiocyanate (FITC) –
labelled H. pylori to ECM proteins. ECM proteins were spotted onto PVDF membranes and
overlaid with FITC labelled bacteria. Adherent bacteria were visualised under UV light. This
shows labelled H. pylori from liquid culture.Where L = Laminin, F = Fibronectin, C = Collagen
IV, LF = Lactoferrin, HSA:H = HSA Hemin complex, HSA = Human Serum Albumin, H =
Hemin, and BSA was used as the control. The green fluorescence is observed as white spots on
the membranes shown above.
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Figure 3.3. Bacterial Overlay: The adhesion of fluorescein-5-isothiocyanate (FITC) –
labelled H. pylori to ECM proteins. ECM proteins were spotted onto PVDF membranes and
overlaid with FITC labelled bacteria. Adherent bacteria were visualised under UV light. This
shows labelled H. pylori from liquid culture under iron reduced conditions. Where L = Laminin,
F = Fibronectin, C = Collagen IV, LF = Lactoferrin, HSA:H = HSA Hemin complex, HSA =
Human Serum Albumin, H = Hemin, and BSA was used as the control. The green fluorescence
is observed as white spots on the membranes shown above.
(3.3) Isolation of Collagen IV Adhesin by Retagging
Having established collagen binding to H. pylori the retagging technology was used in
attempt to isolate the cell surface adhesion responsible for collagen binding.
(3.3.1) Collagen Labelling using Profound Sulfo-SBED Biotin Label
The labelling of Collagen IV with crosslinker was assessed by performing a dot blot
using Streptavidin-HRP as a probe (Figure 3.4.). Figure 3.4(B)clearly shows the biotin
was detected in the labelled collagen-crosslinker conjugate. Figure 3.4(A) (control)
shows no reaction as expected. Thus, it was clear that the crosslinker had been
successfully incorporated onto collagen IV.
  L        C    LF
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(A)                            (B)
Figure 3.4. Construction of crosslinker-collagen conjugate probed with streptavidin HRP.
(A) Unlabelled Collagen (B) Sulfo-SBED tagged Collagen. The collagen with its covalently
attached tag binds to streptavidin-HRP causing luminescence to be observed as a dark spot.
(3.3.2) Identification of Collagen Binding Proteins from H. pylori using
ProFound Sulfo SBED Biotin Label Transfer Kit
Having verified that covalent modification of collagen was successful, direct labelling
of the collagen receptor was attempted.
Initial attempts showed labelling of a number of biotin-tagged proteins detectable by
Western Blot (Figure 3.5, lane 4).  Non specific binding of Strepatavidin was observed
in control experiments under non-reducing and reducing conditions (Figure 3.5, lanes 1
and 2). Streptavidin binding was observed in the presence of bound, tagged Collagen
(Figure 3.5, lane 3). Removal of collagen under reducing conditions showed labelling of
a large number of proteins (See Figure 3.5, lane 4).   It was unlikely that all of these
were collagen receptins and non-specific binding was suspected. Separation of these
proteins was poor and did not allow ready identification of tagged proteins.
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Figure 3.5.  ReTagging Method showing Western blot analysis of biotinylated binding
proteins. After Retagging, biotin tagged proteins were identified by SDS-PAGE and
Streptavidin probed Wetern Blot. Lane (M) is the biotinylated protein molecular weight
standards ladder. Lanes (1) and (2) are controls containing H. pylori alone where (1) is without
reducing agent and (2) is in the presence of reducing agent. Lane (3) shows collagen
crosslinking non-reducing, and (4) shows collagen crosslinking under reducing conditions and
shows detection of putative biotin tagged collagen binding proteins.
To enhance the specificity of the procedure the amount of tagged collagen probe was
increased and, in addition, a larger resolving gel was used to improve protein
separation. Using this approach, labelling of a large number of H. pylori proteins was
still observed (Figure 3.6 Lane 2). This experiment was repeated and gave the same
pattern.  The large number of proteins labelled seemed to indicate extensive non specific
binding of streptavidin-HRP to H. pylori proteins.
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Figure 3.6.  ReTagging Method showing Western blot analysis of biotinylated binding
proteins. After Retagging, biotin tagged proteins were identified by SDS-PAGE and
Streptavidin probed Wetern Blot. Lane (1) is a control containing H. pylori alone. Lane (2)
shows detection of putative biotin tagged collagen binding proteins. Lane (M) is the
biotinylated protein molecular weight standards ladder.
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In order to further purify these potential proteins of interest from proteins that might be
responsible for non-specific binding, magnetic beads were used to enrich or purify a
biotin labelled protein fraction.
(3.3.3) Purification of Biotinylated Proteins using Streptavidin Coated
Magnetic Beads.
Since the Western blot analysis showed up a large number of labelled proteins (section
3.3.2) it was necessary to attempt to further purify these proteins in order to identify
collagen binding protein(s). It was possible, for example, that the crosslinker had bound
non-specifically to other proteins in the immediate vicinity of the collagen IV binding
protein or that some non specific binding of collagen to cell surface proteins was
occurring. Streptavidin coated magnetic beads function as a method of direct isolation
of biotinylated molecules. The beads exhibit low non-specific binding in the presence of
complex biological samples such as cell lysates. These beads were used in order to
enrich and affinity purify a biotinylated collagen adhesion fraction
 (see Section 2.4.4). Figure 3.7 shows SDS-PAGE analysis of the magnetic bead
purification and the Western blot analysis is shown in Figure 3.8.
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Figure 3.7. Retagging of the H. pylori Collagen IV binding protein – Magnetic
bead purification (SDS-PAGE Analysis). After Retagging with crosslinker-collagen
conjugate, biotin tagged proteins were visualised by SDS-PAGE after magnetic-bead-
purification (Section 3.3.3). The figure shows a colloidal Coomassie stained gel where
Lane 1 is the control and Lane 2 the protein fraction eluted from magnetic beads.
Significant protein bands are shown at 77, 66 and 27kDa.
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Figure 3.8. Retagging of the H. pylori Collagen IV binding protein-Magnetic bead
purification (Western blot analysis). After Retagging with crosslinker-collagen
conjugate, biotin tagged proteins were identified by western blotting as described
earlier. Lanes (1) and (2) show blot analysis of biotinylated binding proteins non-
reduced and reduced respectively. Lanes (3) and (4) show blot analysis of proteins
eluted from Streptavidin coated beads where Lane 3 is the control and Lane 4 are the
eluted proteins. Several bands were observed including three that corresponded with
those observed by Coomassie staining at 77, 66 and 27 kDa. A prominent band at 45
kDa was present in the Western blot that was not seen by Coomassie staining. This is
due to the greater sensitivity of Western blot staining.
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The SDS gel showed labelling of a smaller number of proteins than was observed with
Streptavidin interaction with less purified cell suspensions (Figure 3.5 & Figure 3.6).
Major proteins at 77, 67 and 27 kDa were observed in the colloidal Coomassie stained
gel (Figure 3.7).  Proteins with the same molecular weight were observed in the
Western Blot (Figure 3.8).
The approximate size of the proteins was calculated using Relative mobility - Rf
analysis for both the SDS gel and Western Blot (Figure 3.9).
These results were reproduced in subsequent experiments. The protein bands at bands at
sizes 77, 67 and 27 kDa were excised and analysed by Mass Spectrometry (MS) at The
University of St Andrews, Fife, Scotland. The band at 27 kDa was contaminated with
keratin and could not be identified. The pattern obtained in MS analysis identified the
77 kDa protein as H. pylori urease β subunit. This was interesting as urease β subunit is
known to bind CD74 on MHC II and has been shown to bind mucins and some
glycoproteins. The 67 kDa protein was identified by mass spectrometry as H. pylori
catalase.
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Figure 3.9. Graph of Relative Mobility (Rf) Analysis of H. pylori purified biontinylated
proteins. Standard protein mobility data was used to prepare a graph of the relationship
between the molecular weight of standard proteins and their Rf. Graph A shows the Rf analysis
on the SDS Gel (Figure 3.7) and graph B shows the graph prepared by Rf analysis on the
Western blot (from Figure 3.8). The molecular weights of unknown proteins were
calculated using the equation:  log MW = a + b * Rf.
A
B
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(3.4) Urease
Urease is the most abundant H. pylori protein representing 5-8% of total cell protein and
is also associated with the cell surface. It was thought more likely that binding to this
protein was non specific. Therefore, initial investigation instead focussed on catalase
involvement in ECM binding. This finding seemed encouraging and was consistent with
evidence in the literature that catalase was implicated in collagen binding.
(3.5) Purification of H. pylori Catalase
In order to examine collagen binding to catalase it was decided to purify the H. pylori
catalase protein in order to carry out direct studies of collagen binding in vitro.
Indication that catalase was functioning as an adhesin prompted us to attempt
purification of this protein. There were several literature reports to support this finding
and we therefore decided to further explore a collagen catalase interaction. A simple,
one step, protocol for purification of catalase from H. pylori was previously described
by Hazell et al.,(1991). Using this protocol Helicobacter pylori catalase was purified
using FPLC Cation exchange chromatography. The eluate fractions showed a single
peak of protein (Figure 3.10, peak B) and activity.  Catalase activity was confirmed by
checking for oxygen reducing activity using 3% H202. The purity of the eluted catalase
fractions was assessed by 12% SDS-PAGE and the proteins were visualised by
Coomassie Brilliant Blue staining (Figure 3.11).
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Figure 3.10. Elution profile for Purification of H. pylori Catalase by Ion Exchange
Chromatography. A H. pylori cell lysate was applied to the cation exchange column and
eluted by using a salt gradient of 0.1-1M NaCl. Two peaks were apparent on the
chromatogram. Peak A represents the H. pylori flowthrough and B represents H. pylori catalase
protein - fractions A8 –A10. The blue line represents the UV absorbance, the arrow represents
the point of injection of the H. pylori cell lysate, the red dashed lines represent 1ml fractions
collected after injection. The green line represents the salt concentration, and the red dotted line
represents conductivity.
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Figure 3.11. 12% SDS-page gel showing the purification of H. pylori catalase by cation
exchange. Lane M is the molecular weight markers. Lane 1 shows a cell lysate, Lane 2 shows
the flow through the cation exchange column, and Lanes 3 and 4 show purified catalase
fractions A8 and A9 (Figure 3.10) Catalase was observed as a prominent band at ~ 55 kDa. The
SDS-page electrophoresis showed that catalase eluted from the size exclusion column was
substantially pure.  Minor proteins at 30-40 kDa and faint low molecular weight proteins were
the only contaminants.
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(3.6) Investigation of In vitro Collagen Binding to Catalase
Collagen-catalase binding interaction analysis was carried out using gel filtration
chromatography on a superdex 200 gel. Molecular weight standards were applied to the
gel filtration column as described in Section 2.4.7.  Collagen and catalase were applied
separately to the gel filtration column and their elution volumes noted. A collagen
catalase mixture in PBS was incubated for 30 minutes to allow them to bind to one
another before being applied to the column. If binding was successful we would expect
them to elute together at a combined molecular weight of around 250kDa. However, the
elution profile (Figure 3.12) showed that protein eluted from this column across a wide
range of molecular weights and was too varied to usefully demonstrate catalase binding
to collagen IV. The elution over this range of molecular weights may be the result of
self association between collagen monomers and or their association with catalase.
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Figure 3.12. Elution profile of Gel Filtration Chromatography of a mixture of H. pylori
catalase and collagen IV. A Catalase and collagen IV mixture incubated for 30 minutes was
applied to the superdex 200 gel filtration column and eluted in PBS pH 8.0. The blue line
represents the UV absorbance, the arrow represents the point of injection of the protein mixture,
the red dashed lines represent 1ml fractions, and the red dotted line represents conductivity.
Injection
Time (mins)
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(3.7) Binding Assay to test for Collagen IV binding to purified H. pylori
Catalase
It was possible that column chromatography conditions were not suitable as a means to
measure collagen-catalase association. The tendency of collagen monomers to self
associate may have complicated this picture. It was decided to attempt binding assay
measurements to further assess collagen-catalase association. 3% hydrogen peroxide
was used to test for catalase activity.  No catalase activity could be observed using this
assay. Thus, it was not possible to show collagen binding to catalase in vitro. We
therefore decided to examine collagen binding to Urease – the other potential collagen
adhesin identified above (Section 3.3.3).
(3.8) Binding of H. pylori Urease β subunit binding to Collagen IV
In order to verify whether the urease β subunit had a role in collagen adhesion we made
use of a Urease β subunit-negative isogenic mutant available in the laboratory. H. pylori
urease β subunit negative mutant was cultured and FITC labelled as described
previously (Section 3.2). The wildtype H. pylori was used as a control. A dot blot
binding assay was used to assess any differences between mutant and wild-type in
binding by H. pylori to collagen or any of the other ECM proteins. Perhaps surprisingly,
the dotblot showed binding of the H. pylori urease β subunit negative mutant to
collagen, laminin and fibronectin as had been observed before (Figures 3.1, 3.2 and 3.3)
with the wildtype strain (see Figure 3.13A &B). Therefore, we conclude that H. pylori
urease β subunit does not play a role in collagen IV binding. Urease is the most
abundant protein in H. pylori, and therefore it is most likely to be binding to collagen
non-specifically.
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Figure 3.13:  Bacteria overlay method using H. pylori Urease β subunit deficient
strain. A shows the wildtype strain overlay and B shows the Urease β subunit deficient
strain overlay. Where BSA is Bovine Serum Albumin (Control), L is Laminin, F is
Fibronectin, and C is Collagen IV. Binding to collagen is seen as an intense white spot in both
dot blots while binding to Laminin and Fibronectin is less intense.
(3.9) Collagen binding to agar-cultured H. Pylori
In view of the difficulty in showing collagen binding to H. pylori catalase or urease we
decided to examine binding to agar cultured cells. It was possible that the adhesin was
not expressed abundantly in liquid culture. It is well documented that gene/protein
expression profiles are modulated by the growth environment. Figure 3.14 shows a
western blot analysis of biotinylated magnetic bead purified H. pylori proteins from
agar plates. The pattern obtained using agar cultured cells was markedly dissimilar to
that obtained using liquid culture. A corresponding SDS gel was also prepared (data not
BSA     L         F      C
BSA     L          F      C
A
   B
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shown).The main features were bands at ca. 74 and 61 kDa. Although these did not
correspond in molecular weight to the proteins observed by Western blot, these bands
were excised and submitted for Mass spectrometry analysis. This analysis identified
these proteins as urease and elongation factor (EF-tu), both abundant proteins in H.
pylori.
At this point, for reasons that were not clear, a marked variability in western blot
analysis of biotinylated magnetic bead purified proteins was observed. When the
experiment shown in Figure 3.14 was repeated, a different pattern of labelling was
obtained (see Figure 3.15). Despite repeated attempts no consistency in the pattern of
proteins labelled was found.
In an attempt to reduce the complexity and variability of the potential non-specific
interactions it was decided to isolate an outer membrane fraction from H. pylori. Such a
fraction would consist of a smaller number of proteins than whole cell extracts and
would therefore decrease the possibility of nonspecific interaction. It would also have
the effect of producing a fraction enriched with the adhesin which is assumed to be
among the Outer Membrane proteins.
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Figure 3.14. Retagging of the H. pylori Collagen IV binding protein. After
Retagging with crosslinker-collagen conjugate, biotin tagged proteins were identified by
SDS-PAGE/streptavidin blot, magnetic-bead-purified and analysed by Mass
Spectrometric analysis. This figure shows streptavidin blot analysis of samples eluted
from streptavidin coated magnetic beads where Lane 1 is the control and Lane 2 the
eluted protein. LaneM is the molecular weight marker.
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Figure 3.15. Retagging of the H. pylori Collagen IV binding protein. After Retagging with
crosslinker-collagen conjugate, biotin tagged proteins were identified by SDS-
PAGE/streptavidin blot, magnetic-bead-purified and analysed by Mass Spectrometric analysis.
This shows streptavidin blot analysis of samples eluted from streptavidin coated magnetic
beads where Lane 1 is the control and Lane 2 the eluted protein. LaneM is the molecular
weight marker.
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 (3.10) Collagen binding to H. Pylori Outer Membrane Proteins
The Retagging Method gave highly variable and unreliable results, therefore it was
decided to use a another  approach to attempt to identify a Collagen IV binding protein
by extracting the outer membrane proteins, separating them by SDS- PAGE and
transferring them to a PVDF membrane. A similar method had previously been
successful for Pantzar et al.,(1998) in the identification of H. pylori vitronectin and
plasminogen binding proteins.Outer membrane proteins (OMPs) were isolated from H.
pylori as discussed in Materials and Methods (Section 2.5.2).
Figure 3.16 shows an OMP immunoblot incubated with collagen IV. Unbound proteins
were washed away and bound collagen was visualised using an immunoassay. The
assay used anti-collagen antibody, followed by visualisation, using peroxidise labelled
goat anti-rabbit antibodies (Figure 3.16B).  A control OMP immunoblot treated with
antibodies alone (Figure 3.16A). No proteins were detected in B that were not present in
the control, indicating that collagen IV was not binding differentially to any proteins on
the outer membrane fraction.
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              M 1     2     3 1     2     3
Figure 3.16. H. pylori Outer Membrane protein Immunoblot. Outer membrane
proteins from H. pylori were purified and electrophoretically transferred to a PVDF
membrane. The membrane was halved and B was incubated with collagen IV and
probed with anti-collagen and peroxidase conjugated antibodies, and A acted as a
control, probed with antibodies alone, without collagen. Lanes: (1) represents the
sarcosine insoluble outer membrane fraction, (2) represents the sarcosine soluble outer
membrane fraction, and (3) represents the whole cell extract.
We attempted to show binding of tagged collagen to electrophoretically separated outer
membrane proteins. Figure 3.17 shows an OMP immunoblot incubated with
crosslinker-collagen conjugate and streptavidin HRP antibody (Figure 3.17B), along
with a control treated with antibodies alone  (Figure 3.17A). There were no proteins
detected in B that were not present in the control, thus indicating that the crosslinker-
collagen conjugate was not binding to any proteins on the outer membrane fraction.
This receptor overlay method had been successfully used by Ilver et al., (1998) to
identify the BabA adhesin from H. pylori.  That group had used this method to
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characterise the molecular mass of the BabA adhesin by separating protein extracts
using SDS-PAGE, transferring to a PVDF membrane and incubating with a biotinylated
fucosylated blood group antigen Lewis b (Leb) glycoconjugate followed by peroxidase
streptavidin. This method allowed them to identify a 75kDa adhesin, and subsequent
Retagging analysis confirmed this finding.
However, our attempts using the receptor overlay method yielded no definite result in
localising and characterising the collagen IV adhesin. We did not detect unique binding
of the collagen-crosslinker conjugate to any of the purified OMP proteins, that were not
found in the control.
           M     1     2     3           1      2     3
Figure 3.17. H. pylori Outer Membrane Immunoblot. Outer membrane proteins of H.
pylori were purified and electrophoretically transferred to a PVDF membrane. The
membrane was halved and B was incubated with crosslinker-collagen conjugate and
detected with streptavidin HRP. A acted as a control, treating only with streptavidin
HRP. (1)  represents the sarcosine insoluble outer membrane fraction, (2) represents the
sarcosine soluble outer membrane fraction, and (3) represents the whole cell extract.
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Thus, despite repeated attempts and application of a wide variety of techniques we were
unable to demonstrate the presence of a specific collagen IV adhesin in H. pylori. It was
felt that further studies were not warranted.
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Chapter 4
Discussion
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(4.1) General Discussion
This thesis describes our attempts to identify a Helicobacter pylori collagen IV binding 
protein or ahdesin/receptin. A bacterial overlay method was initially employed in order 
to demonstrate binding of FITC-labelled bacteria to extracellular matrix proteins. We 
successfully showed binding of H. pylori to ECM proteins: Laminin, Fibronectin and 
collagen IV. 
Identification of adhesions was attempted using Retagging Technology which employs
a multifunctional crosslinker with a biotin side group. The Retagging technique was 
employed for crosslinker-specific biotin tagging of the putative collagen IV adhesin. 
Further described herein are receptor overlay immunoblots used in an attempt to
identify a specific collagen IV binding protein.
(4.2) Collagen adhesins of H. Pylori
Numerous adhesive properties of H. pylori have been described including epithelial cell 
attachment, hemagluttination, and binding to distinct receptors such as proteins in body 
fluids and proteins of basement membranes (Trust et al, 1991, Gerhard et al., 2001).
Adherence to the ECM is an important mechanism of colonisation for many bacterial 
species. A key feature of many pathogenic bacteria after their initial binding to surfaces 
is the ability to invade deep tissues. Collagen IV is an abundant molecule in the ECM, 
and could represent a major target for binding of microorganisms. Trust et al, 1991, first 
reported H. pylori binding to collagen IV. Since then, no collagen binding protein
(adhesin) has been identified although much work has been carried out on other H. 
pylori ECM adhesins (see Chapter 1, section 1.11). Initial studies focussed on 
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establishing if Collagen IV and other ECM proteins were capable of binding to H. 
pylori. This binding has been reported but in some cases was observed only when 
collagen was in an immobilised form.  Thus, some workers had described collagen 
binding to H. pylori using a radiolabelling technique (Trust et al, 1991). However, other 
workers were only able to show binding to immobilised collagen and suggested that the 
soluble collagen did not bind to H. pylori (Moran et al., 1998).
(4.2.1) Approaches to adhesin identification
(i) Bacterial overlay method
To confirm H. pylori binding to collagen IV and other ECM proteins we used a bacteria 
overlay method. The high specificity and reliability of the overlay method provides us 
with a useful tool for identification of the binding properties of H. pylori to extracellular 
matrix components. The bacteria overlay method has been helpful in searching for 
glycoprotein receptors on eukaryotic cell surfaces (Ruhl et al., 2000) and for identifying 
ligands for bacterial adhesins in complex body fluids (Murray et al., 1992, Ruhl et al.,
2004). Our results confirmed binding of fluorescence labelled bacteria to immobilised 
ECM proteins laminin, fibronectin and collagen IV as described in previous reports 
(Trust et al., 1991). However, we did not observe binding to Lactoferrin, HSA, 
HSA:Hemin complex, or Hemin, despite reports that these proteins bind H. pylori. 
Dhaenens et al., 1997, reported identification of a 70 kDa H. pylori lactoferrin binding 
protein which is only present when H. pylori are grown in an iron-starved medium. Our 
results showed no binding of FITC-labelled bacteria binding to lactoferrin when grown 
under iron reduced conditions. However, it is interesting that Walz et al., 2005, have 
shown the H. pylori J99 strain binding to lactoferrin using a bacterial overlay method,
without growing the H. pylori in an iron reduced medium.
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Binding to laminin and collagen IV was consistent with previous reports (Trust et al.,
1991) where high affinity binding of H. pylori to both proteins was revealed. These 
workers reported that the H. pylori adhesins appear to be surface proteins, since
treatment with trypsin or proteinase K and boiling the cells significantly reduced 
binding. They proposed that binding to these two major basement proteins is highly 
conserved among H. pylori strains.
It has been suggested that H. pylori only expresses ECM receptins during the stationary 
phase of growth, and other factors including growth medium, pH, iron availability and 
redox potential can have effects on binding (See Dubreuil et al., 2002 for a review). 
Moran et al., (1993) proposed in their concluding remarks that because microaerophillic 
conditions are required to demonstrate reproducible binding to ECM proteins, it
suggests that certain metabolic activity may be involved in binding. They support this
proposal by adding that decreased binding to ECM has been observed by aberrant forms
of H .pylori that may be non viable, which has been observed among other 
microaerophillic bacteria (Moran and Upton, 1987). They further proposed that the 
receptin or adhesin may be absent from aberrant forms. From our data, binding of 
FITC-labelled H. pylori to laminin, fibronectin and collagen IV was not affected by the 
growth conditions of the bacteria, as bacteria when harvested from Columbia agar 
plates, liquid culture, and iron reduced liquid culture, were shown to bind all three ECM 
proteins. It is important to note however, that as binding was observed by visualising 
the fluorescence of bound bacteria under a UV light source, there was no precise 
method used to measure binding affinities. These findings demonstrate that the bacterial
overlay method is a useful tool for exploration and characterisation of unknown 
adhesion specificities of Helicobacter pylori and other bacteria.
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(ii) Receptor Activity-directed Affinity Tagging (Retagging) technique for 
Adhesin Protein Identification
The Retagging method involves a technique based on a receptor covalently attached to a 
multi functional crosslinker, which following UV irradiation, transfers a biotin tag to 
the bound adhesin. After detergent solubilization the adhesin can be extracted by use of 
streptavidin coated magnetic beads. Ilver et al., (1998) successfully identified the BabA 
adhesin in H. pylori using this technique and later the H. pylori SabA adhesin was 
identified by retagging (Mahdavi et al., 2002). Possible drawbacks of this method 
include protein precipitation, poor labelling of bait protein, poor photoactivation, non 
specific binding of probe, and steric hindrance.
Retagging with the crosslinker-collagen conjugate first isolated 3 proteins at ~ 77, 66 
and 27kDa. Mass spectrometric analysis identified that the 77kDa protein was identical 
to H. pylori Urease β subunit. The 66kDa protein was identical to H. pylori catalase.
Although we assumed these results to be aberrant or artefactual at first, investigation of 
the literature provided us with a body of evidence to support this finding.
Catalase is present in a variety of bacteria and protects the bacterial cell against the 
toxic effects of oxygen radicals, for example, those produced during the oxidative burst 
of phagocytosis. The H. pylori catalase protein has been previously characterised and 
cloned showing a gene katA and a 58.6 kDa protein (Hazell et al., 1991, Odenbreit et 
al., 1996). The protein purified from H. pylori by Lingwood et al., (1993) and the katA 
gene product produced in E. coli both run with an apparent molecular massof 62 or 63 
kDa in the SDS gel, which is higher than the calculated molecular mass of the KatA 
protein described byHazell and coworkers. Although catalase is normally thought of as
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a cytoplasmic protein in H. pylori, examination of the literature revealed that this was
not the first time catalase was implicated in adhesion. Lingwood et al., (1993) identified 
a 63 kDa protein suggested to be a lipid binding adhesin of H. pylori which 
corresponded to the N-terminal of katA. In addition to this, Pantzer et al., (1998) 
identified a vitronectin binding protein from H. pylori which had an amino terminal 
sequence identical to that of H. pylori catalase. The isolated vitronectin protein showed 
92% identity with the H. pylori catalase amino terminal amino acid sequence. The 
observation of catalase binding to vitronectin was encouraging as it demonstrated 
binding of catalase to an extracellular matrix protein, as well as providing evidence that 
catalase might function as an adhesin in H. pylori.
Several previous studies had noted the binding capabilities of catalase. For instance,
catalase adheres to smooth muscle cells (Sundaresan et al., 1995) and it also binds β-
amyloid, a major component of the plaques observed in Alzheimer’s disease (Milton
1999). Yano et al (2004) investigated catalase binding to mitogenic signalling 
molecules. Serum stimulation of HeLa, Caco-2 and LiSa-2 cells resulted in catalase 
binding to the signalling molecule Gbr2. In addition, stimulation with the ECM proteins 
fibrinogen, fibronectin, and laminin, but not collagen types I-V, resulted in binding of 
the cells in a manner similar to that of serum. It is interesting to note that collagen 
stimulation did not result in binding of catalase to Gbr2. If catalase does in fact, bind 
collagen, then collagen might bind to catalase before Gbr2.
A study by Visai et al (1990) used 125I labelled collagen to study the binding of 
collagens to an enterotoxigenic strain of E. coli. The specificity of 125I labelled collagen 
binding to E. coli was examined by analysing the inhibitory activity of different 
collagen types and catalase, a non collagenous protein. All the collagens tested were 
potent inhibitors and showed essentially the same inhibitory potential when tested at 
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different concentrations. These workers state that binding of 125I labelled collagen to 
bacteria in the presence of catalase was not significantly reduced. Our findings do not 
support this observation. In their data, when the concentration of catalase was increased 
the inhibitory effect of catalase increased, with a maximum inhibition of binding 125I 
labelled collagen of approximately 20-25%. From our viewpoint when looking at the 
potential of catalase binding to collagen this is significant inhibition, and suggests that 
catalase might compete with the bacteria for binding to collagen.
Furthermore, Peterson et al (2004) found that Extracellular Superoxide Dismutase (EC-
SOD) binds to type I collagen. Like catalase, EC-SOD has a role in detoxification of 
reactive oxygen species. The EC-SOD has a C-terminal heparin-binding region which 
mediates its interaction with collagen. The bound EC-SOD is thought to protect 
collagen from oxidative fragmentation during oxidative stress. These findings were of 
interest, as they showed an enzyme, similar to catalase, interacting with collagen.
From our findings and evidence presented in the literature it seemed plausible that 
catalase could be the binding protein on H. pylori for collagen IV. A rapid convenient 
protocol for H. pylori catalase purification had been described by Hazell et al.,(1991).
We purified H. pylori catalase using cation exchange chromatography and examined in-
vitro Collagen binding to H. pylori catalase (see section 4.3). Catalase was identified a 
second time as a potential collagen receptor, when H. pylori were grown from liquid 
culture and retagging was performed. This time the Western blot detected corresponding 
biotinylated proteins of the same size as catalase when Rf analysis was carried out. 
These results were reproducible. The fact that catalase was detected a second time lead 
us to believe that it may in fact bind collagen IV. There was certainly strong evidence in 
the literature to support this observation. However, our attempts to investigate collagen-
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catalase association (Section 4.3) had been unsuccessful and no further work was 
carried out to investigate this.
Repeating the crosslinking experiment using bacteria harvested from agar culture did 
not yield the same results as had been observed with liquid culture. Catalase was not
identified in subsequent labelling experiements and therefore this raised doubts whether 
catalase was truly implicated in H. pylori binding to collagen IV. Magnetic bead 
purification yielded proteins on SDS gels that were not observed on corresponding 
streptavidin blots, indicating that non-specific binding may have been occurring.
The second protein identified by Mass spectrometric analysis was H. pylori Urease 
enzyme β subunit. Like catalase much of urease is found in the cytoplasm of the 
bacteria (Scott et al., 2002). However, it has also been shown to be present in 
association with the outer membrane (Bode et al., 1993, and Rokita et al., 2000).
Literature reports pointed to the possibility of urease acting as an adhesin. H. pylori 
urease has been shown to bind gastric mucin, heparin, and related heparinoids (Icatlo et 
al., 1998) and it has been suggested that urease binds to lipopolysaccharide on the 
bacterial surface (Icatlo et al., 2000). Fan et al., (2000) have shown that urease binds to 
Class II MHC on gastric epithelial cells and H. pylori urease β subunit binds to CD74 
on gastric epithelial cells (Beswick et al., 2005). 
With this evidence it was decided to examine urease binding further. A H. pylori urease 
β subunit negative mutant strain was available in the laboratory. The dotblot method is a 
fast, effective way of measuring binding interactions of bacteria to proteins and was 
employed for this purpose. The urease β subunit negative mutant strain was labelled 
with FITC and used in binding analyses of the mutant strain to ECM proteins spotted on 
a PVDF membrane. If urease was involved in collagen binding we would expect to see 
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little or no binding to collagen by the urease negative strain when compared to the 
wildtype strain. However, binding occurred to all three ECM proteins, collagen, 
fibronectin and laminin, in the mutant strain as well as the wildtype. This indicated that 
the urease β subunit in H. pylori was unlikely to be implicated in collagen binding. One 
possibility not evaluated in this study is that there might be more than a single collagen 
adhesin in H. pylori.  If this were the case and there was an element of redundancy in 
the system then deletion of a single ‘adhesin’ would not necessarily impact on or 
abrogate collagen binding significantly.  Alternative methods to evaluate the affinity of 
the interaction would be required. 
One interesting result worth noting was the identification of H. pylori EF-Tu elongation 
factor as a potential adhesin. Initially this finding was considered a false positive, as it 
was thought that this protein did not normally function as an adhesin. However, Dallo et 
al., (2002) described a role for EF-Tu in mediating adhesion of bacteria to the 
extracellular matrix. They reported that the Mycoplasma pneumonia EF-Tu elongation 
factor mediates binding to the ECM component fibronectin through the carboxyl region 
of the EF-Tu. Balasurbramanian et al., (2009) further explored this interaction, 
comparing Mycoplasma pneumonia to closely related Mycoplasma genitalium. Here 
they found that M. genitalium EF-Tu, despite having 96% identity to M.  pneumonia
EF-Tu, does not bind to fibronectin. This showed that there were critical amino acids 
involved in M. pneumonia binding to fibronectin.  Further surface-associated EF-Tu 
proteins from other microorganisms including Lactobacillus johnsonii, Listeria 
monocytogenes & Pseudomonas aeruginosa were reported to bind mucin (Granato et 
al., 2004),  fibrinogen (Schaumburg et al., 2004),  plasminogen and factor H (Kunert et 
al., 2007). From this data it is interesting that H. pylori EF-Tu was identified in this 
current study as a potential collagen receptor. This was not reproduced.
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(iii) Immunoblot and Receptor overlay Technique
As the retagging method was proving unsuccessful in our attempt to identify the H. 
pylori collagen IV binding protein, we decided to explore alternative methods.
Several groups have used radiolabelling of ECM proteins as a method for identification 
of ECM receptins on microorganisms. This method was not an option for us as
radioactivity handling was not possible in the laboratory. We decided to examine
immunoblotting techniques. Pantzar et al., (1998) described a method they used for the 
identification of H. pylori vitronectin and plasminogen binding proteins. This method 
involved extracting the outer membrane proteins (OMP’s) from H. pylori. In the case of 
gram negative bacteria, many of the surface proteins are constituents of the outer 
membrane. Pantzar et al., separated OMP proteins on a SDS gel and transferred them to 
a PVDF membrane. The membranes were firstly incubated with vitronectin or 
plasmonogen, followed by anti vitroncetin or anti plasmonogen antibodies, and finally
developed using peroxidase conjugated antibodies. In this way, they could identify the 
proteins to which the ECM proteins were binding to on the immunoblot. These 
workers found a 57kDa vitronectin binding protein (identical to H. pylori catalase) and 
a 42 and 57 kDa plasminogen binding protein.
Outer membrane proteins were isolated from H. pylori using ultracentrifugation in the 
presence of sarcosine (See Results section 3.9). Doig et al., (1994) used sarcosine as a 
method for extracting OMP’s and this method was shown to extract a higher number of 
protein species than other preparation methods. This method yields two protein 
preparations; a sarcosine soluble fraction and a sarcsoine insoluble fraction. The outer 
membrane fraction is insoluble in sarcosine, whereas the cytoplasmic membrane is fully
soluble (Filip et al., 1973). Both fractions were analyzed by immunoblotting, as well as 
the whole cell extract. The protein fractions transferred onto the PVDF membranes were 
85
incubated with collagen IV and an immunoblot procedure was carried out. If collagen 
IV had interacted with any of the proteins then we would expect to detect a unique 
species that was not present in the control immunoblot - no unique proteins were
observed in the test immunoblot. Although these attempts were unsuccessful, this 
method was robust and reliable and had been successful in other studies.
In attempts to further identify collagen IV binding proteins, it was decided to probe a 
collagen-crosslinker conjugate using a immunoblot procedure. H. pylori OMP’s were 
transferred to a PVDF membrane and then incubated with a collagen-crosslinker 
conjugate. Streptavidin HRP was used to detect binding interactions between the 
collagen conjugate and any of the H. Pylori OMPs proteins. This method resulted in 
blots with high backgrounds and a number of electrophoresis bands indicating that non-
specific binding remained a problem. However, we did not observe any unique protein 
band in the immunoblot that was not present in the control. This method had worked 
successfully for Ilver et al., (1998) in their initial attempts at localizing the H. pylori
BabA adhesin and they describe it as a “receptor overlay technique”. 
Either of these immunoblot methods, if successful, would have provided us with an 
indication of the size of the H. pylori collagen binding protein. There are no literature 
reports to suggest the molecular weight of the protein, although it would be useful to 
know the approximate size of the protein we were trying to identify. When Pantzar et 
al., (1998) used the vitroncetin immunoblot procedure, it allowed them to identify a 57 
kDa protein, and 2D electrophoresis was used to identify and purify this protein from a 
crude guanidine-HCl cell extract.
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(4.3) In Vitro Collagen binding to H. pylori Catalase
Gel filtration chromatography was used in an attempt to observe collagen IV binding to
purified H. pylori catalase in vitro. These attempts however, were inconclusive as the 
gel filtration chromatography gave rise to several peaks and it was difficult to determine
what these peaks represented. Collagen IV is a large, hydrophobic protein with low 
water solubility and it is possible it may have precipitated in the column. Thus there was 
the possibility that collagen might self associate or associate with one or more catalase 
molecules to produce equilibrium mixtures containing a large number of protein 
species.
In further attempts to examine collagen IV binding to catalase we coated 96 well plates 
with collagen IV, blocked with BSA and incubated with catalase. After washing we 
added hydrogen peroxide to check for a bubbling effect indicating the presence of 
catalase. We did not observe a catalase activity in the wells.  In a few instances a
minimal bubbling effect was thought to be observed but was unconvincing. Since we 
used BSA as a blocking agent, it was difficult to know for certain whether this minimal 
bubbling effect was a result of residual BSA, as BSA dissolved in solution can cause 
foam or bubbles.
(4.4) Difficulties with Identification of the Collagen IV Adhesin.
The identification of the H. pylori collagen binding protein has proven difficult. This 
may be the reason why the collagen binding protein has not been identified to date, 
despite the fact that collagen IV is the major protein present in basement membranes. 
Considering there has been much research carried out on H. pylori interactions with 
other proteins of the ECM, it is somewhat surprising that no collagen binding proteins 
have been identified so far. 
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Although Trust et al., (1991) described high affinity binding of H. pylori to collagen IV, 
Moran et al., (1993) reported different observations. While the latter group found strong 
binding of H. pylori to laminin, they could not demonstrate binding to collagen IV in
any of the strains tested. Moran et al., found that none of the strains were capable of 
binding soluble proteins, but a proportion bound immobilised laminin, fibronectin and 
types I and V collagens. They suggest that in the immobilised form the protein is open 
and extended, whilst in the soluble form the protein might be folded, thereby not 
presenting the appropriate binding site for bacterial adhesion. This folded state in the 
soluble form was observed for fibronectin in a previous report (Rocco et al., 1987). 
Moran et al., (1993) also propose that it is the insoluble form that is tissue associated in 
vivo, and due to this, the immobilised form may better reflect the ECM as bacteria 
would encounter it in vivo. Another observation to note is that despite Trust et al, (1991) 
reporting that binding to laminin and collagen IV is conserved among H. pylori strains, 
Moran et al., (1993) found binding of some but not all strains of H. pylori to laminin, 
but none to collagen IV, emphasising inter-strain differences in specificity. This binding 
to immobilized and but soluble forms of proteins has been observed in other studies of 
interactions of bacteria with ECM proteins. Lactobacillus acidophilus binds to 
immobilised collagen I and fibronectin but not soluble forms (Lorca et al., 2002).
Reports that Yad A of Yersinia enterocolitica and P fimbriae of Escherichia coli bind 
immobilised but not soluble fibronectin may reflect the fact that these adhesins 
recognise a domain which is exposed only when fibronectin is immobilised in tissues 
(Schulze-Koops et al., 1993 and Westerlund et al., 1991)
Therefore, these findings suggest that from our results, even although H. pylori binds 
collagen IV when immobilised on PVDF membranes, it may not bind collagen in the 
soluble form. Collagen is in its soluble form in the retagging method, and it might be
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possible that its binding sites are not accessible at this time. This could explain our 
variable results when the beads are used to purify biotinylated proteins after the 
retagging method. The collagen was also in a soluble form during our collagen/ 
collagen-crosslinker conjugate immunoblot procedure, and this could explain the fact 
that we did not detect any binding interaction.
(4.5) Conclusion and Future work
Arising from the work presented in this thesis it is evident that further exploration is 
required in order to identify the collagen IV receptor on H. pylori.
It is clear to see that investigations into H. pylori and other microorganisms binding host 
ECM proteins has much potential in the role of treating infection. 
Future work that we would suggest would be to construct a H. pylori catalase negative 
strain as catalase was identified by mass spectrometry on two occasions as a potential 
collagen binding protein. There is also a good amount of evidence to support this result. 
However, our own attempts to characterise this interaction were unsuccessful. After 
construction of a catalase mutant we would suggest using the Biocore to characterise 
this interaction. This instrument has been successfully used by other members in this
laboratory to examine protein-protein interactions. This experiment should finally rule 
out the possibility of catalase as a collagen IV binding protein on H. pylori.
Other methods of binding protein identification might include affinity purification,
using a sepharose resin coupled to collagen, and applying a H. pylori cell lysate.
There are also the options of radiolabelling and ELISA to further characterise binding 
activities.
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It is evident from previous reports and our own bacterial overlay method that H. pylori
binds collagen IV. Therefore an adhesin most likely is present on the surface of the 
pathogen. However, identification of this adhesin protein has proven challenging.
90
References
Alberts B, Johnson A, Lewis J, Raff M, Roberts K and Walter P (2007) Molecular 
Biology of the cell 5th Ed. New York. Garland Science. Taylor & Francis Group.
Alvarez-Olmos MI and Oberhelman RA (2001) Probiotic agents and infectious 
diseases: a modern perspective on a traditional therapy. Clin Infect Dis. 32: 1567–1576.
Ascencio, F., L. A. Fransson, and T. Wadstrom (1993) Affinity of the gastric
pathogen Helicobacter pylori for the N-sulphated glycosaminoglycan heparan
sulphate. Journal of Medical Microbiology. 38:240–244.
Balasubramanian S, Kannan TR, Hart JP and Baseman JB (2009) Amino acid 
changes in Elongation Factor Tu of Mycoplasma pneumoniae and Mycoplasms 
genitalium influence fibronectin binding. Infection and Immunity. 77:3533-3541
Beswick EJ, Pinchuck IV, Minch K, Suarez G, Sierra JC, Yamaoka Y and 
ReyesVE (2005) Helicobacter pylori Urease β subunit binds to CD74 on gastric 
epithelial cells and induces NFkB activation and Interleukin-8 production. Infection and 
Immunity. 74:1148-1158
Blaser MJ (1992) Hypothesis on the pathogenesis and natural history of Helicobacter 
pylori-induced inflammation.Gastroenterology. 102:720-7.
Bode G, Malfertheiner P, Lehnhardt G, Nilius M and Ditschuneit H (1993)
Ultrastructural localisation of urease of Helicobacter pylori. Med. Microbiol. Immunol. 
(Berlin). 182:233-242
Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R 
and Covacci A (1996) Cag, a pathogenicity island of Helicobacer pylori encodes type-I 
specific and disease associated virulence factors. Proc. Natl. Acad. Sci. USA. 93:14648-
14653.
Chung, A.E., R. Jaffe, I.L. Freeman, J.P. Vergnes, J.E. Braginski, and B. Carlin
(1979) Properties of basement membrane-related glycoprotein synthesized in culture by 
a mouse embryonal carcinoma-derived cell line. Cell. 16:277–287. 
Chung AE.(1993)Laminan. In Zern MA and Reid LM (Ed.) Extracellular matrix: 
Chemistry, biology and pathobiology with emphasis on the liver. New York. Marcel 
Dekker Inc. Ch.2
Chung AE. (1995)Laminan. In Haralson MA and Hassell JR (Ed.). Extracellular 
Matrix: A practical approach. New York. Oxford University Press. p108-118.
Cover TL and Blaser MJ (1992) Purification and characterization of the vacuolating 
toxin from Helicobacter pylori. J. Biol. Chem. 267:10570-10575.
Cover TL, Hanson PI, and Heuser JE (1997) Acid induced dissociation of VacA the 
Helicobacter pylori cytotoxin reveals its pattern of assembly. J Cell. Biol. 138:759-769.
91
Crowe SE. (2005) Helicobacter infection, chronic inflammation, and the development 
of malignancy. Current Opinion in Gastroenterology 21:32-38.
Dallo SF, Kannan TR, Blaylock MW, and Baseman JB (2002)
Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex
act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol. 
46:1041–1051.
de Bentzmann S, Plotkowski MC, and. Puchelle E (1996). Receptors in the 
Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. Am. 
J. Respir. Crit. Care Med 154: 155-162
Dhaenens L, Szczebara F, and Husson MO. (1997) Identification,
characterization, and immunogenicity of the lactoferrin-binding protein from 
Helicobacter pylori. Infect. Immun., 65, 514–518.
Doig P, and Trust TJ. (1994) Identification of surface-exposed outer membrane 
antigens of Helicobacter pylori. Infect. Immun. 62:4526-4533.
Dubreuil JD, Del Giudice G and Rappuoli R. (2002) Helicobacter pylori Interactions 
with Host Serum and Extracellular Matrix Proteins: Potential Role in the Infectious 
Process. Microbiology and Molecular Biology Reviews. 66: 617-629.
Evans D J, Evans DG, Takemura T, Nakano H, Lampert HC,
Graham DY, Granger DN, and Kvietys PR. (1995). Characterization of
a Helicobacter pylori neutrophil-activating protein. Infect. Immun. 63:2213–
2220.
Fabrizius-Homan DJ, Cooper SL.(1991) Competitive adsorption of vitronectin with 
albumin, fibrinogen, and fibronectin on polymeric biomaterials. J Biomed Mater Res
25:953–71.
Fan X, Gunasena H, Cheng Z, Espejo R, Crowe SE, Ernst PB and Reyes VE. 
(2000) Helicobacter pylori urease binds to Class II MHC on gastric epithelial cells and 
induces their apoptosis. J. Immunol. 165:1918-1924
Filip C, Fletcher G, Wulff JL &  Earhart CF. (1973) Solubilisation of the 
cytoplasmic membraneof Escherichia coli by the ionic detergent sodium-
laurysarcosinate. Journal of Bacteriology 115:717 – 722
Furthmayr H. (1993) Basement Membrane collagen: structure assembly and 
biosynthesis. In Zern MA and Reid LM (Ed.) Extracellular matrix: Chemistry, biology 
and pathobiology with emphasis on the liver. New York. Marcel Dekker Inc. Ch.7.
Gerhard M, Hirmo S, Wadström T, Miller-Podraza H, Teneberg S, Karlsson K.A, 
Appelmelk BJ, Odenbreit S, Haas R, Arnqvist A, and Borén T. (2001) Helicobacter 
pylori, an adherent pain in thestomach. In Achtman, M., (ed.). Helicobacter pylori: 
Molecularand Cellular Biology. Horizon Scientific Press, Wymondham, UK,pp. 185–
206.
92
Gobert A P, Mersey B D, Cheng Y, Blumberg D R, Newton J C, Wilson K T.
(2002).Cutting Edge: Urease release by Helicobacter pylori stimulates macrophage 
inducible nitric oxide synthase. J Immunol. 168:6002-6006
Granato D,. Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, and
Corthesy-Theulaz IE (2004). Cell surface-associated elongation factor Tu
mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human
intestinal cells and mucins. Infect. Immun. 72:2160–2169.
Gristina AG. (1987). Biomaterial-centered infection; microbial adhesion versus
tissue integration. Science.237:1588-95.
Hardin F and Wright RA. (2002). Helicobacter pylori: review and update. Hospital 
Physician. 38:23-31
Harris AG, and Hazell SL. (2003). Localisation of Helicobacter pylori Catalase in 
both the periplasm and cytoplasm, and its dependence on the twin arginine target 
protein KapA for activity. FEMS Microbiology Letters.224:283-289.
Hazell SL, Evans Jr DJ and Graham DY. (1991). Helicobacter pylori Catalase. J. 
Gen. Microbiol. 137:57-61.
Herrmann M, Suchard S J, Boxer LA, Waldvogel FA & Lew P. (1991).
Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal 
adherence to surfaces. Infect Immun 59: 279–288
Hudson, BG, ST Reeders, K Tryggvason.(1993). Type IV collagen— structure, gene 
organization, and role in human diseases—molecular basis of Goodpasture and Alport 
syndromes and diffuse leiomyomatosis. J Biol Chem 268:26033–26036
Husson MO, Legrand D, Spik G and Leclerc H. (1993). Iron acquisition by 
Helicobacter pylori: importance of human lactoferrin. Infect Immun. 61:2694-2697
Hynes R. O. Fibronectins. Springer-Verlag. New York 1990.
Icatlo, FC, Goshima H, Kimura N and Kodama Y. (2000). Acid dependent 
adherence of Helicobacter pylori urease to diverse polysaccharides. Gastroenterology. 
119:358-367
Icatlo FC, Kuroki M, Kobayashi C, Yokoyama H, Ikemori Y, Hashi T and 
Kodama Y. (1998). Affinity purification of Helicobacter pylori urease. Relevance to 
gastric mucin adherence by urease protein. Journal of Biological Chemistry. 273:18130-
18138
Ilver D, Barone S, Mercati D, Lupetti P and Telford JL (2004). Helicobacter pylori
toxin VacA is transferred to host cell via a novel contact dependent mechanism. Cellular 
Microbiology. 6:167-174.
93
Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik E, Berg DE, Covacci 
A, Engstrand L and Boren T. (1998). Helicobacter pylori adhesin binding fucosylated 
histo-blood group antigens revealed by Retagging. Science. 279:373-377.
Joh D, Wann ER, Kreikemeyer B, Speziale P, and Höök, M.(1999). Role of 
fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian 
cells. Matrix Biol 18: 211–223.
Josenhans C, Labigne A and Suerbaum S.(1995). Comparitive Ultrastructural & 
Functional studies of Helicobacter pylori & Helicobacter mustelae flagellin mutants: 
both flagellin subunits FlaA and FlaB are necessary for full motility in Helicobacter
species. Journal of Bacteriology. 177:3010-3020.
Kadler KE, Baldock C, Bella J, and Boot-Handford RP. (2007). Collagens at a 
glance. J Cell Sci.120:1955–1958.
Kalluri R. (2003). Basement membranes: structure, assembly and role in tumour 
angiogenesis.Nature Reviews Cancer. 3:422-433.
Karaca C, Guler N, Yazar A, Camlica H, Demir K, and Yildirim G. (2004). Is 
lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant 
women with hyperemesis gravidarum? Turkish Journal of Gastroenterology 15:86-89.
Kefalides NA. (1973). Structure and biosynthesis of basement membranes. 
International Review of Connective Tissue Research. 6:63-104.
Khin M M, Ringner M, Aleljung P, Wadstrom T, and Ho B (1996). Binding of 
human plasminogen and lactoferrin by Helicobacter pylori coccoid forms. J. Med. 
Microbiol. 45:433-439.
Kronvall G & Jonsson K (1999). Receptins: a novel term for an expanding
spectrum of natural and engineered microbialproteins with binding properties for 
mammalian proteins. J. Mol. Recognit.12:38–44.
Kunert, A., J. Losse, C. Gruszin, M. Huhn, K. Kaendler, S. Mikkat, D. Volke,
R. Hoffmann, T. S. Jokiranta, H. Seeberger, U. Moellmann, J. Hellwage, and
P. F. Zipfel (2007). Immune evasion of the human pathogen Pseudomonas
aeruginosa: elongation factor Tuf is a factor H and plasminogen binding
protein. J. Immunol. 179:2979–2988.
Kuusela P (1978). Fibronectin binds to Staphylococcus aureus. Nature. 27:718–720
Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature. 227:680-685.
Lee YK, Lim CY, Teng WL, Ouwehand AC, Tuomola EM,
and Salminen S. (2000). Quantitative approach in the study of adhesion of lactic acid 
bacteria to intestinal cells and their competition with enterobacteria. Appl. Environ. 
Microbiol. 66:3692–3697.
94
Leunk R D, Johnson P T, David B C , Kraft W G, and Morgan D R. (1988). 
Cytotoxic activity in broth culture filtrates of Campylobacter pylori. J.Med.Microbiol. 
26:93-99.
Lingwood CA, Wasfy G, Han H and Huesca M.(1993). Receptor Affinity 
Purification of a lipid binding Adhesin from Helicobacter pylori. Infection & Immunity. 
61:2474-2478.
Ljungh, A., A. P. Moran, and T. Wadstrom (1996). Interactions of bacterial
adhesins with extracellular matrix and plasma proteins: pathogenic implications
and therapeutic possibilities. FEMS Immunol. Med. Microbiol.16:117–126.
Lorca G, Torino MI , Font de Valdez G and Ljungh A. (2002). Lactobacilli express 
cell surface proteins which mediate binding of immobilized collagen and fibronectin.
FEMS Microbiology Letters 206: 31-37
Lottenberg, R., D. Minning-Wenz, and M. D. P. Boyle. (1994). Capturing host
Plasmin(ogen): a common mechanism for invasive pathogens? Trends Microbiol.
2:20–24.
Mahdavi, J., Sondén, B., Hurtig, M., Olfat, F.O., Forsberg, L., Roche, N.,
Ångström, J., Larsson, T., Teneberg, S., Karlsson, K.A., and others. (2002) 
Helicobacter pylori SabA adhesin in persistent infection andchronic inflammation. 
Science 297: 573–578.
Malfertheiner P, Megraud F, O’Morain C, Hungin A P S, Jones R, Axon A, 
Graham D Y, Tytgat G, & The European Helicobacter Study Group (EHPSG).
(2002). Current concepts in the management of Helicobacter pylori infection-the 
Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther.16:167-80.
Mamo W, Boden M & Flock, J.I. (1994). Vaccination with Staphylococcus aureus
fibrinogen-binding proteins (FgBPs) reduces colonisation of Staphylococcus aureus in a 
mouse mastitis model. FEMS Immunol Med Microbiol 10: 47–53.
Mamo W, Froman G, Muller HP. (2000). Protection induced in mice vaccinated with 
recombinant collagen-binding protein (CnBP) and alpha-toxoid against intramammary 
infection with Staphylococcus aureus. Microbiol Immunol 44: 381–384.
Marshall B J and J R Warren (1994). Unidentified curved Bacilli in the stomachs of 
patients with gastritis and peptic ulceration. Lancet i:1311-1315.
Marshall BJ, Armstrong JA, McGechie DB and RJ Glancy.(1985). Attempt to fulfil 
Koch’s postulates for pyloric Campylobacter. Med. J. Aust. 142:436-439.
Menaker RJ, Sharaf AA, and Jones NL. (2004). Helicobacter pylori infection and 
gastric cancer: host, bug, environment, or all three? Current Gastroenerology Report 
6:429-435.
95
Milton NGN. (1999). Amyloid-β binds catalase with high affinity and inhibits 
hydrogen peroxide breakdown. Biochem. J. 344:293–296
Mine T, Maraoka H, Saika T, Kobayashi I (2005) Characteristics of a clinical isolate 
of urease negative Helicobacter pylori and its ability to induce gastric ulcers in 
Mongolian gerbils. Helicobacter 10: 125-31
Mobley, H. L. (1996). The role of Helicobacter pylori urease in the pathogenesis
of gastritis and peptic ulceration. Aliment. Pharmacol. Ther. 10:57–64.
Moran, A. P. & Upton, M. E. (1987). Factors affecting productionof coccoid forms by 
Campylobacter jejuni on solid media duringincubation. J Appl Bacteriol 62, 527-537.
Moran, A. P., P. Kuusela, and T. U. Kosunen. (1993). Interaction of Helicobacter
pylori with extracellular matrix proteins. Journal of Applied Bacteriology. 75:184–
189.
Morris A, Nicholson G. (1987). Ingestion of Campylobacter pylorides causes gastritis 
and raised fasting gastric pH. Am J Gastroenterol 82:192-199.
Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M and Ohori H. (2002).
Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic 
Lactobacillus reuteri. FEMS Immunology and Medical Microbiology 32:105–110.
Murray PA, Prakobphol A, Lee T, Hoover CI, Fisher SJ (1992). Adherence of oral 
streptococci to salivary glycoproteins. Infect Immun 60:31–38.
Neeser JR, Granato D, Rouvet M, Servin A, Teneberg S and
Karlsson KA. (2000). Lactobacillus johnsonii La1 shares carbohydrate-binding 
specificities with several enteropathogenic bacteria. Glycobiology. 10: 1193–1199.
Nemcova R, Bomba A, Herich R and Gancarcikova S.(1998). Colonization 
capability of orally administered Lactobacillus strains in the gut of gnotobiotic piglets. 
Dtsch Tierartzl Wochenschr 105:199–200
Neri D & Bicknell R. Tumour Vascular Targeting. (2005). Nature Reviews Cancer
5:436-446
O’Toole, P. W., M. Kostrzynska, and T. J. Trust. (1994). Non-motile mutants
of Helicobacter pylori and Helicobacter mustelae defective in flagellar hook
production. Mol. Microbiol. 14:691–703.
Odenbreit S, Wieland B and Haas R. (1996). Cloning and Genetic Characterisation of 
Helicobacter pylori Catalase and Construction of a Catalase deficient Mutant Strain. 
Journal of Bacteriology. 178: 6960-6967.
Odenbreit S. (2005). Adherence properties of Helicobacter pylori impact on 
pathogenesis and adaptation to the host. International Journal of Medical Microbiology. 
295:317-324.
96
Pankov R & Yamada KM. (2002). Fibronectin at a glance. Journal of cell science. 
115:3861-3863.
Pantzar, M., A. Ljungh, and T. Wadstrom. (1998). Plasminogen binding and
activation at the surface of Helicobacter pylori CCUG 17874. Infection and
Immunity.66:4976–4980.
Pantzar M. 1998. Interactions of Vitronectin and Plasminogen with Helicobacter 
pylori. PhD. Lund University, Sweeden.
Papine E, Zoratti M, Cover T L. (2001). In search of the Helicobacter pylori VacA 
mechanism of action. Toxicon. 39. 1757-1769.
Parsonnet J, Friedman GD, Vandersteen DP. (1991). Helicobacter pylori infection 
and the risk of gastric carcinoma. N Engl J Med. 325: 1127-31.
Pascu C, Hirmo S, Ljungh Å, and Wadström T.(1995). Inhibition of extracellular 
matrixn and serum protein binding to Staphylococcusaureus by heparin and various 
polysulphated agents. Med. Microbiol. Lett. 4:397-405.
Patti J M and Hook M. (1994). Microbial Adhesins recognising extracellular matrix 
macromolecules. Curr. Opin. Cell. Biol. 6:752-758.
Peek RM Jr. (2003). Intoxicated cells and stomach ulcers. Nat.Genet. 33.228-330.
Petersen SV, Oury T, Oestergaard L, Valnickova Z, Wegrzyn J, Thogersen IB, 
Jacobsen C, Bowler RP, Fattman CL, Crapo JD. et al. (2004) Extracellular 
superoxide dismutase (EC-SOD) binds to type I collagen and protects against oxidative 
fragmentation. J. Biol. Chem. 279, 13705–13710
Phadnis SH, Parlow MH, Levy M, Ilver D, Caulkins CM, Connors JB, Dunn 
BE.(1996). Surface localization of Helicobacter pylori urease and a heat shock protein 
homolog requires bacterial autolysis. Infect Immun 64:905-912
Prinz C, Hafsi N, and Voland P. (2003). H. pylori Virulence factors and the host 
immune response: implications for therapeutic vaccination. Trends Microbiol. 11:134-
138.
Proctor RA.(1987). Fibronectin: a brief overview of its structure, function, and
physiology. Rev. Infect. Dis. 9: S317-S321. 
Proctor RA. (1988). Fibronectin and microbial pathogenesis. Curr. Opin. Infect. Dis. 
1:912-918.
Radcliff FJ, Hazell SL, Kolesnikow T, Doidge C and Lee A. (1997). Catalase a novel 
antigen for Helicobacter pylori vaccination. Infect Immun. 65:4668-4674.
Ringner, M., K. H. Valkonen, and T. Wadstrom. (1994). Binding of vitronectin
and plasminogen to Helicobacter pylori. FEMS Immunol. Med. Microbiol.
9:29–34.
97
Rocco, M, Infusini E., Daga MG, Gogioso L and CunibertiC. (1987) Models of 
fibronectin. EMBO Journal 6:2343-2349.
Rokita E, Makristathis A, Hirschl AM, Rotter ML (2000). Purification of surface 
associated urease from Helicobacter pylori. J. Chromatography. 737:203-212.
Ruggiero P, Pepploni S, Rappuol R, Del Giudice G. (2003). The quest for a vaccine 
against Helicobacter pylori: How to move from mouse to man? Microbes Infect 5:749-
56.
Ruhl S, Cisar JO, Sandberg AL. (2000). Identification of polymorphonuclear 
leukocyte and HL-60 cell receptors for adhesins of Streptococcus gordonii and 
Actinomyces naeslundii. Infection and Immunity. 68:6346-6354.
Ruhl, S., Sandberg, A.L., and Cisar, J.O. (2004) Salivary receptors for the
proline-rich protein-binding and lectin-like adhesins of oral actinomyces
and streptococci. J. Dent. Res., 83:505–510.
Ruiz-Bustos, E., A. Sierra-Beltran, M. J. Romero, C. Rodriguez-Jaramillo,
and F. Ascencio. (2000). Protection of BALB/c mice against experimental
Helicobacter pylori infection by oral immunisation with H. pylori heparan
sulphate-binding proteins coupled to cholera toxin beta-subunit. Journal of Medical
Microbiology. 49:535–541.
Salama, N. R., Otto, G., Tompkins, L. & Falkow, S. (2001)Vacuolating cytotoxin of 
Helicobacter pylori plays a roleduring colonization in a mouse model of infection. 
Infection and Immunity. 69:730–736 
Sambrook JF, Fritsch EF, Maniatis T. 1989. Molecular cloning. A laboratory 
manual. 2nd Edition, Cold Spring Harbour Laboratory Press. Cold Spring Harbour 
NY.
Schaumburg, J., O. Diekmann, P. Hagendorff, S. Bergmann, M. Rohde, S.
Hammerschmidt, L. Jansch, J. Wehland, and U. Karst. (2004). The cell wall
subproteome of Listeria monocytogenes. Proteomics 4:2991–3006.
Schennings,T., Heimdahl,A., Coster,K., and Flock,J.I. (1993). Immunization with 
fibronectin binding protein from Staphylococcus aureus protects against experimental 
endocarditis in rats. Microb. Pathog. 15: 227-236.
Schulze-Koops, H., Burkhardt, H., Heesemann, J., Kirsch,T., Swoboda, B., Bull, 
C., Goodman, S., Emmrich, F. (1993).Outer membrane protein YadA of 
enteropathogenicYersiniae mediates specific binding to cellular but notplasma 
fibronectin. Infect. Immun. 61:2513–2519
Scott DR, Marcus EA, Weeks DL and Sach S. (2002). Mechanisms of acid resistance 
due to the urease system of Helicobacter pylori. Gastroenterology. 123:187-195
98
Schwarzbauer J. (1999). Basement membranes: putting up the barriers. Curr Biol 9: 
R242–R244.
Styriak I, Nemcova R, Chang YH, Ljungh A. (2003). Binding of extracellular
matrix molecules by probiotic bacteria. Lett Appl Microbiol. 37:329–333
Suerbaum S, Josenhans C and Labigne A. (1993). Cloning and Genetic 
Characterisation of the Helicobacter pylori and Helicobacter mustelae flab flagellin 
genes and Construction of Helicobacter pylori flaa- and flab- negative mutants by 
electroporation – mediated allelic exchange. Journal of Bacteriology. 175:3278-3288.
Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T.(1995). Requirement for 
generation of H2O2 for platelet-derived growth factor signal transduction. 
Science.;270:296–299. 
Switalski, L. M., Speziale, P. & Höök, M. (1989). Isolation and characterization of a 
putative collagen receptor from Staphylococcus aureus strain Cowan 1. J Biol 
Chem.264:21080-21086.
Telford JL, Ghiara P, Dell’Orco M, Comanducci M, Burroni, D,
Bugnoli M, Tecce MF, Censini S, and Covacci C. (1994). Gene structure of the 
Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. 
Med. 179: 1653–1658.
Testerman TL, McGee DJ, Mobley HLT. (2001). Adherance and Colonization. P381-
417. In HLT Mobley, GL Mendz, & SL Hazell (ed). Helicobacter pylori: Physiology 
and Genetics. ASM Press Washington DC.
Timpl, R., H. Rohde, P.G. Robey, S.I. Rennard, J.M. Foidart, and G.R. Martin. 
(1979). Laminin - a glycoprotein from basement membrane. J. Biol. Chem. 254:9933–
9937. 
Towbin H, Staehelin T, and Gordon J. (1979). Electrophoretic transfer of proteins 
from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. 
PNAS. 79:4350-4354.
Trust TJ, Doig P, Emody L, Kienle Z, Wadstrom T, and O’Toole Paul. (1991).
High-Affinity Binding of the Basement Membrane Proteins Collagen Type IV and 
Laminan to the Gastric Pathogen Helicobacter pylori. Infection and Immunity. 59:
4398-4404
Utt, M, Danielsson B, and Wadstrom T. (2001). Helicobacter pylori vacuolating
cytotoxin binding to a putative cell surface receptor, heparan sulfate,
studied by surface plasmon resonance. FEMS Immunolog. Med. Microbiol.
30:109–113.
Vaudaux P, Pittet D, Haeberli A, Lerch P G, Morgenthaler J J, Proctor RA , 
Waldvogel FA. & Lew DP. (1993). Fibronectin is more active that fibrin or fibrinogen 
in promoting Staphylococcus aureus adherence to inserted intravascular devices. J 
Infect Dis 167: 633-641
99
Valkonen, K. H., M. Ringner, A. Ljungh, and T. Wadstrom. (1993). High affinity
binding of laminin by Helicobacter pylori. Evidence for a lectin- like
interaction. FEMS Immunol. Med. Microbiol. 7:29–38.
Valkonen, K. H., T. Wadstrom, and A. P. Moran. (1994). Interaction of
lipopolysaccharides of Helicobacter pylori with basement membrane protein
laminin. Infection and Immunity. 62:3640–3648.
Valkonen, K. H., T. Wadstrom, and A. P. Moran. (1997). Identification of the
N-acetylneuraminyllactose-specific laminin-binding protein of Helicobacter
pylori. Infection & Immunity. 65:916–923.
Vanet A., Labigne A. (1998) Evidence for specific secretion rather than autolysis in the 
release of some Helicobacter pylori proteins. Infect. Immun. 66: 1023–1027.
Visai L, Speziale P & Bozzini S. (1990). Binding of Collagens to an Enteretoxigenic 
strain of Escherichia coli. Infection & Immunity 58:2:449-445.
Walz A, Odenbreit S, Mahdavi J, Borén T, and Ruhl S. (2005). Identification and 
characterization of binding properties of Helicobacter pylori by glycoconjugate arrays. 
Glycobiology. 15:7:700-708.
Westerlund B, van Die I, Kramer C, Kuusela P, Holthöfer H, Tarkkanen AM, 
Virkola R, Riegman N, Bergmans H, Hoekstra W, Korhonen TK (1991) 
Multifunctional nature of P fimbriae of uropathogenic Escherichia coli: mutations in 
fsoE and fsoF influence fimbrial binding to renal tubuli and immobilized fibronectin. 
Mol Microbiol
5: 2965–2975.
Westerlund B., and Korhonen TK. (1993). Bacterial proteins binding to the 
mammailain extracellular matrix. Mol. Microbiol.9:687-694.
Xiao, J., Hook, M., Weinstock, G. M. & Murray, B. E. (1998). Conditional 
adherence of Enterococcus faecalis to extracellular matrix proteins. FEMS Immunol 
Med Microbiol. 21: 287–295
Yahiro K, Niidome T, Kimura M, Hatakeyama T, Aoyagi H, Kurazono H, 
Imagawa K, Wada A, Moss J and Hirayama T. (1999). Activation of Helicobacter 
pylori VacA toxin by alkaline or acid conditions increases its binding to a 250 kDa 
receptor protein tyrosine phosphatase β. J.Biol. Chem. 274:36693-36699.
Yano S, Arroyo N, Yano N. (2004). Catalase binds Grb2 in tumor cells when 
stimulated with serum or ligands for integrin receptors. Free Radic Biol Med. 15: 1542-
54.
100
101
Appendix A
Reagents and Buffers
SDS-PAGE/protein purification reagents
10X Phosphate Buffered Saline 
Reagent Volume/Quantity
Na2HPO4.2H2O (8mM) 14.24 g
KH2PO4 (1.5mM) 2.04 g
NaCl (137mM) 80.0 g
KCl (2.7mM) 2.0 g
Adjust pH to 7.4 and make up to 1Litre Volume
Resolving Gel Buffer
Reagent Volume/Quantity
Tris Base 18.165g
Distilled Water 100 mls
Adjust to pH 8.8 with concentrated HCL
Stacking Gel Buffer
Reagent Volume/Quantity
Tris Base 12.11 g
Distilled Water 100 mls
Adjust to pH 6.8 with concentrated HCL
10% Ammonium Persulphate
Reagent Volume/Quantity
APS 50 mg
Distilled Water 1 ml
Prepare fresh prior to use
10X Running Buffer
Reagent Volume/Quantity
Tris base 30 g
Glycine 114 g
SDS 5.0 g
Distilled Water 1000 ml
Dilute 1:10 prior to use
5X Reducing Sample Buffer
Reagent Volume/Quantity
Glycerol 5 ml
β-mercaptoethanol 6.25 ml
20% SDS 5 ml
1.0M Tris pH 6.8 1.25 ml
0.2% Bromophenol Blue 0.3 ml
Make up to 25 ml with distilled water
Coomassie Blue R-250 Gel Stain
Reagent Volume/Quantity
Coomassie Brilliant Blue 
R250
0.5g
Methanol 200 ml
Glacial Acetic Acid 35 ml
Distilled Water 265 ml
Destain Solution
Reagent Volume/Quantity
Methanol 400 ml
Glacial Acetic Acid 70 ml
Distilled Water 265 ml
Coomassie Blue G-250 stain (for Mass spectrometry)
Fixation Solvent
Reagent Volume/Quantity
50% Methanol 500 ml
2% Phosphoric acid 85% 23.5 ml
Distilled Water 480 ml
Incubation Solvent
Reagent Volume/Quantity
34% Methanol 500 ml
2% Phosphoric acid (85%) 23.5 ml
17% Ammonium sulphate 170 g
Distilled Water 640 ml
Destain Solution
Reagent Volume/Quantity
Methanol 400 ml
Glacial Acetic Acid 70 ml
Distilled Water 530 ml
Immunoblotting
Blocking Solution 5%
Reagent Volume/Quantity
Skimmed dried milk powder 5 g
PBS 100 ml
0.1% Tween Washing Solution
Reagent Volume/Quantity
Tween 20 1 ml
PBS 1000 ml
Primary and Secondary Antibody Diluent Solution 5%
Reagent Volume/Quantity
Skimmed dried milk powder 5 g
PBS 100ml
Transfer Buffer
Reagent Volume/Quantity
Tris base 2.9 g
Glycine 1.45 g
SDS 0.185 g
Methanol 100ml
Make up to 500ml with distilled water
Membrane Stripping Buffer
Reagent Volume/Quantity
Tris base pH 6.8 (25.5mM) 6.25 ml
β-mercapthoethanol 
(100mM)
0.68 ml
SDS (2%) 20 ml
Make up to 100ml final volume with distilled water
Developing Solution
Reagent Volume/Quantity
Iodophenol 4 mg
Luminol 12 mg
DMSO 0.5 ml
0.1M Tris pH 8.8 50 ml
H2O2 18 μl

